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The features of aging  
 
Aging is a multidimensional process that involves 
physical, psychological and social changes. In humans, 
aging has been viewed as the declining function of most 
body systems as the result either of the progressive 
accumulation of damaged tissue and substances or the 
progressive loss of normal tissue and substances either by 
intrinsic or extrinsic mechanisms, already after 30 years old. 
This phenomenon  is gradual and progressive, although 
variable for each individual. Elderly people are characterized 
by the impairment of homeostatic processes, that leads to an 
increased susceptibility and vulnerability to stressing events 
and diseases. The less homeostatic ability depends of:  
1. Reduced functional reserve of each organ and 
system by aging (intrinsic aging process), living place and 
lifestyle (extrinsic aging process); 
2. Functional loss of major integration systems 
(nervous, endocrine and immune system) which play a 
coordination role of homeostatic functions. 
A major age-related health issue is the increasing 
prevalence and severity of infectious diseases, which are the 
fourth most common cause of death in the elderly (Heron 
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MP et al., 2007). Indeed, aging is associated with an 
increased incidence of infections such as viral influenza, 
respiratory syncitial virus (RSV) and pneumococcal 
pneumonia (Nicholson KG et al., 1997). Elderly people also 
have an increased incidence of bacterial infection in lungs, 
urinary tract, skin and other tissues and a higher incidence of 
tuberculosis and herpes zoster reactivation (Ginaldi L et al., 
2001; Bulati M et al., 2011). Vaccination has only limited 
success since aging is also associated with poor protective 
antibody response to vaccines, indeed, it has been 
demonstrated that the currently vaccines protect only a small 
proportion of the elderly population (Weinberger B et al., 
2008). 
 The increase in the elderly population is an important 
phenomenon in our society strictly dependent on health care 
progress, antibiotics vaccination and improving life 
standards caused a dramatic increase in lifespan and a 
consequent reduction of the overall morbidity and mortality 
(Troen BR, 2003). By 2050, almost 40% of the European 
and US population is predicted to be older than 60 years old 
(Lutz W. et al., 1997). Nonetheless, the extreme limit of life 
is not changed. 
The immune system  is a dynamic system that is highly 
dependent on the regenerative ability of hematopoietic 
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precursor cells that is constantly  challenged by external and 
internal forces threatening the homeostasis of the system. It 
is not surprising that the immune system undergoes dramatic 
changes with age. These changes occur in all leukocytes and 
accordingly, affect innate and adaptive immune functions. 
Innate immune responses are a first step toward the 
development of adaptive immune responses, and age-related 
deficits in innate immune functions might therefore alter 
both cell-mediated and humoral adaptive immune reactions 
(Mills KHG, 2009). The progressive and cumulative 
modifications of immune system over the lifespan, known as 
“Immunosenescence” (Franceschi C et al., 1995; Pawelec G 
et al., 2005), have a major impact on the capacity to respond 
to immune challenge. Several years ago, Franceschi C et al. 
proposed the “remodelling theory of ageing” according to 
which, during aging, clonotypical immunity deteriorates, 
while ancestral innate/natural immunity is largely conserved 
or even up-regulated with age. The peculiar remodeling of 
immunosenescence, probably, expresses the balance 
between chronic antigenic stress faced by the organism, and 
its intrinsic ability to respond to it as well as other stressor 
(e.g. free radicals). In a recent paper, it was shown as some 
functions are impaired while others remain unchanged or 
even increased (Bürkel A et al., 2007). However, 
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Immunosenescence is primarily responsible for the 
diminished ability of older individuals to overcome 
infections (Globerson A and Effros RB, 2000). Indeed, it 
was demonstrated that, although elderly people are able to 
mount  anamnestic responses, don’t show good ability to 
establish a primary type response against new antigens 
(Fagnoni FF et al., 2000).  
A typical feature of aging is a chronic, low-grade pro-
inflammatory status observed in the old people that,  is 
potentially linked to the most important age-related diseases. 
So, aging increases risk of disabilities and chronic diseases, 
such as cardiovascular diseases, arthrosis, arthritis, 
neurodegeneration, cancer, atherosclerosis, metabolic 
syndrome, osteoporosis, sarcopenia and frailty (Gao HM and 
Hong HS, 2008; Ginaldi L et al., 2005; Florez H et al., 2006; 
Rajala MV et al., 2003). In  this context, elderly people are 
characterized by a general increase in the production of pro-
inflammatory cytokines and inflammatory markers 
(Cevenini E et al., 2010). CRP and fibrinogen, the major 
clinical markers of inflammation, have been associated  with 
coronary disease, myocardial ischemia and myocardial 
infarction, in association with IL-1, IL-1ra, IL-6, IL-6ra, IL-
18, TNF-α , serum amyloid A and ICAM-1 (Chung HY et 
al., 2006; Van Den Biggelaar AH et al., 2004; Ferrucci L et 
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al., 2005). Some  investigators identified an age-related 
increase of IL-6 and TNF-α, defining them as markers of 
functional disability and as predictors of disability and 
mortality among the elderly (Bruunsgaard H et al., 2003a, b, 
c). Moreover, IL-6, defined as “cytokine for gerontologists” 
(Krabbe KS et al., 2004; Fulop T et al., 2006), may 
negatively impact hematopoiesis either by inhibition of 
erythropoietin production or interaction with erythropoietin 
receptors (Eisenstaedt R et al., 2006). In contrast, TNF-α has 
been found to induce production of the Alzheimer Amyloid 
beta peptide, increase its toxicity and upregulate smooth 
muscle cell proliferation during atherosclerosis development 
(Wick G et al., 2000; Saurwin-Teissl M et al., 2000). 
Another group demonstrated an increase in serum interferon-
γ-inducible chemokines (MIG and IP-10), eotaxin, a 
chemoattractant for eosinophils, and TNFR-II with the 
advanced age. On the other hand, serum levels of EGFR and 
EGF, important regulators of cell growth, proliferation and 
differentiation, decreased with aging (Shurin GV et al., 
2007). The consequence of this situation is that age-
dependent up-regulation of the inflammatory response, 
termed “Inflamm-aging” (inflammation and aging) 
(Franceschi C et al., 2000), render elderly prone to frailty 
(Balistreri CR et al., 2008; Franceschi C et al., 2005; Lio D 
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et al., 2004; Pes et al., 2004). Anyway, the inflamm-aging 
theory fails in separating true physiological aging and true 
pathological aging during natural aging process (Goto M, 
2008). The concept of inflamm-aging coincides with 
antagonistic pleiotropy theory of aging  postulating that 
aging is the late deleterious effect of genes (pro- and anti-
inflammatory), that are beneficial at an earlier stage of life 
for the development and maintenance of body integrity 
against infectious agents and stressors (Goto M, 2008). The 
physiological aging process and many age-related diseases 
may due to the continuous exposure to stressors, such as 
reactive oxygen species (ROS) and reactive nitrogen species 
(RNS), that activate NFκB, which has a central position in 
the inflammatory reaction, controlling expression of 
different inflammatory and oncogenic genes (Chung HY et 
al., 2006; Dinarello CA, 2006).  Several studies have shown 
the strong link between inflammation and chronic infections 
with the initiation and progression of atherosclerosis. 
Exposition to Clamydia Pneumoniae and Helicobacter Pilory 
have been associated to atherosclerotic tissues in humans, 
suggesting like these microorganisms may act stimulating 
the vessel-associated leukocytes or inducing the 
transformation of vascular muscles or vascular endothelial 
cells (Libby P et al., 1997). Latent cytomegalovirus (CMV) 
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infection appears to accelerate immune aging (Pawelec G et 
al., 2005; Akbar AN and Fletcher JM, 2005). The 
relationship between chronic CMV infection and adverse 
health outcomes was evaluated in the Swedish 
OCTO/NONA studies, in which anti-CMV IgG 
seropositivity was included as one of the very important 
immunological parameters defining an immunological risk 
profile (IRP) predicting 2, 4 and 6 years of mortality 
(Pawelec G et al., 2005). IRP was defined by a cluster of 
immunological parameters: inverted CD4:CD8 ratio, poor T 
cell proliferative response to mitogens, low interleukin-2 
production, accumulation of late-stage differentiated CD8+ 
T cells, decreased B cell count. In addition, other studies 
reported associations between CMV seropositivity or anti-
CMV IgG titres and higher levels of IL-6 as predictor of 
incident frailty and mortality (Schmaltz HN et al., 2005; 
Wang GC et al., 2010). Moreover, detectable CMV DNA 
rather than anti-CMV IgG titres was associated with high 
serum levels of neopterin, an immune activation marker 
produced by monocytes and macrophages, which, in turn, is 
associated with frailty in the elderly (Leng SX et al., 2011a, 
b). CMV is considered a cofactor that enhances progression 
to AIDS (Griffiths PD, 2006) and infection with this herpes 
virus, has been associated with poor clinical response to 
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influenza vaccination in the elderly (Trzonkowski P et al., 
2003). Increased levels of inflammatory mediators are 
associated with dementia, like Parkinson’s and Alzheimer’s 
disease. Inflammation clearly occurs in pathologically 
vulnerable regions of the Alzheimer's disease (AD) brain, 
where damaged neurons and neurites and highly insoluble 
amyloid beta peptide deposits and neurofibrillary tangles 
provide obvious stimuli for inflammation (Akiyama H et al., 
2000).   
 
 
 
Modification of the immune system 
during aging 
 
The thymus is the primary lymphoid organ where T cells 
mature; it undergoes dramatic structural changes with age as 
thymopoietic niches disappear, while the thymic 
perivascular space increases. These changes are associated 
with a loss of thymic epithelial cells and thymocytes and 
with the predominance of adipocytes that inﬁltrate the 
perivascular space (Dixit VD, 2010). These age-related 
modifications result in a gradually and  progressive thymus 
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output abatement; the thymus activity  becomes insufficient 
to replace the naïve T cells lost in the periphery and to 
maintain the size of the T cell repertoire (Kohler S et al., 
2005; Naylor K et al., 2005). The loss of naïve T cells is due 
to cumulative exposures  to foreign pathogens and 
environmental antigens that promotes the accumulation of 
memory and effector T cells with age (Saule P et al., 2006). 
One of the most evident change in the memory T cell 
population during aging is the clonally expansion of 
CD8+CD28- T cells. These appear as senescent cells as they 
have short telomeres, produce  Tumor Necrosis Factor α 
(TNF- α), are resistent to apoptosis and show reduced  
proliferative capacity (Pawelec G et al., 2008; Globerson A 
and Effros RB, 2000). During aging, T cells lose the ability 
to produce and respond to IL-2 resulting in a great 
impairment in T cell function (Desai A et al., 2010). Many 
authors have associated the reduced expression of IL-2 by 
human T lymphocytes, with the  defective activation of 
transcription factors AP-1 and NF-AT during aging with 
(Haynes I et al., 1999; Nagel JE et al., 1988; Whisler RL et 
al., 1996).  
The percentage and the absolute number of circulating 
CD3+ T lymphocytes and of CD4+ and CD8+ T cell subsets 
decreases with age (Pawelec G et al., 2002; Cossarizza A et 
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al., 1996). The natural reduction of naïve T cells, coupled 
with the narrowing of the T cell repertoire, has profound 
consequences for immune function, rendering elderly people 
less responsive to immune stimulation and vaccination, as 
well as predisposing them to cancer (Hakim FT, Gress RE, 
2007). Memory and  naïve human T cells have been 
distinguished for long time on the basis of CD45 family 
members on their surface. Indeed, CD45RA antigen is 
expressed primarily on naïve T lymphocytes, while 
CD45RO is present on the surface of memory T cells. Upon 
contact with antigen, some activated T lymphocytes become 
effector after asymmetric division, while others form clones 
of memory cells. Both subpopulations are CD45RO+, but 
phenotypes apparently “naïve” (CD45RA+) were also found 
among the memory T cell pool. Indeed, CD45RA re-
expression by late-differentiated memory T lymphocytes, 
makes this marker not fully  useful  to discriminate between 
naïve and memory cells (Hamann D et al., 1997). Hence, the 
need to use more T  cell surface markers for a better 
classification, including: CD28/CTLA4, CD27, CD62L, 
CD95, CD95L, CD7, CD11a, CD103, CCR7. Naïve T 
lymphocytes are characterized by the absence of CD95 and 
by the presence of CD45RA, CD62L, CD27 and CD28 
(Gupta S et al., 2005). Moreover, memory T cells also 
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exhibit adhesion molecules, like CD62L, and the chemokine 
receptor CCR7, that allow them to adhere to the endothelial 
wall, migrate and pass through vessels to reach the 
peripheral sites.  The deep characterization of memory T 
lymphocytes has revealed the existence of distinct 
populations of memory: the  central memory (TCM) and 
effector memory (TEM) cells characterized by distinct 
homing capacity and effector function. The former, 
identified as CD45RA-CCR7+CD62L+, principally located 
in the lymph nodes, is a population of memory T cell less 
differentiated,  (Nociari MM, Telford W, Russo C, 1999); 
the latter, CD45RA-CCR7-CD62L-, is a highly mature T 
cell population located in extranodal tissues and mucous 
membranes; it has been  shown to be responsible for the 
tissue damage which characterizes many autoimmune 
diseases, as itcan rich sites of inflammation in non-lymphoid 
tissues, while not participating in the process of lymphoid 
recirculation carried out by most other lymphocytes. Once 
divided into TCM and TEM, according to the expression of 
CCR7 and CD62L, these populations have been further 
classified by the presence/absence of the  costimulatory 
molecules CD27 and CD28 (Gupta S et al., 2004). Some 
“reverted” memory T cells express again CD45RA, so they 
become terminally differentiated and functionally anergic 
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(TEMRA), with a characteristic phenotype: 
CD45RA+CCR7-CD28-CD27-CD62L- (Gupta S et al., 
2005). Another classification is based on the expression of 
two inhibitory receptors expressed by late-stage 
differentiated cells, CD57 and KLRG1, sometimes referred 
to as markers of “senescence”. CD57 is expressed on the 
surface of NK cells and late-stage CD8+ T cells, while on 
CD4+ its expression is reduced. On the other hand, KLRG1 
is largely expressed on CD4+ as well as CD8+ T 
lymphocytes and NK cells (Ouyang Q et al., 2003; Larbi A 
et al., 2009; Pellicanò M et al., 2011). Many evidences have 
shown that CMV, which establishes persistent, usually 
asymptomatic, life-long infection, has an enormous impact 
on the distribution of T cell subsets in most old people, 
which show a clonal expansion of CMV-specific CD4 and 
CD8 T lymphocytes (Looney RJ et al., 1999; Chidrawar S et 
al., 2009; Almanzar G et al., 2005, Pawelec G et al., 2005). 
CMV-specific T cells typically display an effector memory 
phenotype of late-stage differentiation. CMV also modulates 
innate immunity and induces the production of cytokines and 
chemokines which affect T cell immunity. So, the typical 
consequence of aging is the progressive filling of the 
“immunological space” by activated lymphocytes in 
response to chronic/continuous stress either from 
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pathological or physiological antigens stimuli  (Goto M, 
2008) . Moreover the cytokines and chemokines play a 
central role in the generation of the  “inflammed” milieu, 
typical of ageing.  Ageing is also associated with a shift from 
the Th1 to the Th2 cytokine profile in response to immune 
stimulation. The overproduction of Th2 cytokines could 
increase B cell mediated autoimmune disorders by 
enhancing the production of autoreactive antibodies. In  
recent  years,  an  important  role  of  CD4+CD25+Fox3+ 
regulatory T cells (Treg) in the maintenance of immune 
homeostasis has been described (Wing K et al., 2005; Mills 
KHG, 2009). Aged individuals show an increase of Treg 
cells, but the lack of IL-7 receptor (CD127) expression on 
the surface of these cells results in their functional 
impairment. It has been  suggested  that a decrease in Treg 
cell numbers or function could result in autoimmune 
diseases or rejection of a transplant, while an excess of Treg 
lymphocytes might contribute to poor responses to infectious 
diseases, vaccines and cancer (Rouse BT et al., 2006).   
Most researchers have studied the impairment of cell-
mediated immune response during aging, although B cell 
function is also modified in the elderly (Cancro MP et al., 
2009; Frasca D, Blomberg BB, 2011; Buffa S et al., 2011). 
Moreover, the humoral immune response of elderly people is 
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qualitatively and quantitatively diminished when compared 
with the immune response of young people. Age-associated 
changes in the composition of peripheral B cells reflect both 
increased B cell longevity and decreased B cell generation 
(Kline GH et al., 1999). Many authors have described a 
decrease both in percentage and absolute number of total 
CD19+ B lymphocytes (Paganelli R et al., 1992; Colonna 
Romano G et al., 2003; Shi Y et al., 2005; Frasca D et al., 
2008; Faria AM et al., 2008; Veneri D et al., 2009). In 
addition, defects in hematopoietic stem cells (HSC), that 
influence B lymphopoiesis,  have been described in aging. 
These defects consist in: failure in telomere maintenance 
(Warren LA et al., 2009; Weng NP, 2008), epigenetic 
modifications (Issa JP, 2003), decrease in lymphopoiesis and 
contemporary increase in myelopoiesis process (Kim M et 
al., 2003; Cho RH et al., 2008), altered development in bone 
marrow (Mehr R et al., 2003), shrinkage of B cell repertoire 
(Guerretaz LM et al., 2008). Indeed, it has been 
demonstrated an age-related reduction of the absolute 
number of B cell precursors in the bone marrow (BM) (Kline 
GH et al., 1999); however, B lymphopoiesis persists 
throughout adult life (Rossi MI et al., 2003). Reduced B cell 
generation in aged BM is also due to decreased IL-17 
production (Tsuboi I et al., 2004) and impaired V-DJ 
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rearrangement (Gibson KL et al., 2009). In aged people, it 
has been described a change in the B cell repertoire, 
particularly in the heavy chain of BCR. In elderly people, the 
extended survival of memory B cells and the clonal 
expansion contribute to the limited repertoire and to the 
collapse in B cell diversity that are correlated with the 
impairment of antibody response and poor health status 
(Miller JP, Cancro MP, 2007; Kumar R et al., 2008; Gibson 
KL et al., 2009; Dunn-Walters DK et al., 2010; Ademokun 
A et al., 2011). Moreover, the amount of the different Ig 
isotypes changes with age: in fact, although the number of B 
cells is decreased, the serum concentration of IgG, IgA and, 
to a lesser extent, IgE is increased. On the contrary, both 
IgM and IgD are decreased (Listì F et al., 2006; Frasca D et 
al., 2008). So the immunoglobulins produced during an 
anamnestic response are preserved, whereas the Igs typically 
produced by naïve B cells are reduced.  
Naïve B cells express surface IgD, whereas “classical” 
memory B cells carry switched Igs (IgG, IgA and IgE). On 
the other side memory B cells are characterized by the 
presence of somatic hypermutation in their Ig variable gene 
sequences (Klein U et al., 1998) and most of them are 
CD27+, so, CD27 has been considered the typical marker of 
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memory B cells (Agematsu K et al., 2000)  and IgD the 
typical marker of naïve B cells.   
Nevertheless, the description of  an IgD+ subset 
expressing somatically mutated Ig genes failed to use this 
marker to unequivocally distinguish between naïve and 
memory B lymphocytes (Klein U et al., 1998).  
 
On these basis the combination of IgD and CD27 surface 
markers, allowed to characterize three distinguished B cell 
subpopulations : 
1) IgD+CD27- Naïve B cells 
2) IgD+CD27+ Unswitched memory B cells 
3) IgD- (IgG+ or IgA+)CD27+ Switched memory B 
cells  
     By using these two markers it has been demonstrated 
that naïve  B cells are  significantly reduced in the elderly 
(Gupta S et al., 2005; Colonna-Romano G et al., 2008), 
although other authors have described the increase of naïve 
B cells in the elderly (Shi Y et al., 2005; Frasca D et al., 
2008). Moreover, Frasca D et al. (2008) have  report no 
changes of the absolute number of these cells in the old 
people.  
During last years, many authors have demonstrated the 
presence in the blood of a memory B cell subset that lack 
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CD27 (Anolik JA et al., 2004;  Fecteau JF et al., 2006; Wei 
C et a., 2007; Colonna-Romano G et al., 2009; Cagigi A et 
al., 2009). The expansion of this IgD-CD27- (DN) memory 
B cell population has been demonstrated in healthy elderly 
(Colonna-Romano G et al., 2009), in active Lupus patients 
(Wei C et al., 2007), in healthy subjects challenged with 
respiratory syncitial virus (RSV) (Sanz I et al., 2008) and in 
HIV patients (Cagigi A et al., 2009). So, this phenomenon is 
probably the consequence of a persistent stimulation of the 
immune system. So, these data suggest that also CD27 
cannot be used as an unequivocal marker useful to 
distinguish naïve from memory B cells. The complexity of 
the memory B cell pool and the discrediting of the “dogma”: 
IgD and IgM=naïve, switched Igs=memory,  has been 
further demonstrated by the evidence of a IgM memory B 
cell population identified as IgM+IgD+CD27+ and of the 
“IgM only” memory B cells identified as  IgD- 
IgM+CD27+. 
It was suggested that IgM memory B cells are generated 
in  the spleen and control S. Pneumoniae infections 
(Kruetzmann S et al., 2003; Weller S et al., 2004; Shi Y et 
al., 2005). Moreover, the decline of IgM memory B cell pool 
in the elderly, could be involved in defective immune 
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responses against infections by encapsulated bacteria (Shi Y 
et al., 2005; Buffa S et al., 2011).  
Recently, two developmentally regulated markers, CD38 
and CD24, were used for a better discrimination between 
naïve and memory B subpopulations. In this way, in the 
human B cell compartment, two naïve and six memory B 
cell subsets were defined (Fecteau JF et al., 2006; 
Palanichamy A et al., 2009; Blair PA et al., 2010; 
Berkowska AM et al., 2011):  
1) CD38hiCD24hi Transitional B cells 
2) IgM+CD27- Naïve mature 
3) IgD+IgM+CD27+ Natural effector or IgM      
memory 
4) IgD-IgM+CD27+ IgM-only 
5) IgG+/IgA+CD27+  “Classical” Switched memory 
6) IgD- IgG+/IgA+CD27- DN B cells  
Human peripheral blood CD19+CD38hiCD24hi B cells, 
identified as immature transitional B cells have regulatory 
capacity and they are also known as Breg (Blair PA et al., 
2010). Indeed, these cells suppress the differentiation of T 
helper 1 cells, in part via the provision of interleukin-10 
(IL-10). These cells are expanded  in different patients 
suffering of lymphoma and autoimmune diseases, such as 
SLE and rheumatoid arthritis (RA) (Palanichamy A et al., 
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2009; Blair PA et al., 2010).  Blair et al (2010) has observed 
also that in SLE patients, these cells loss their suppressive 
capacity, producing less IL-10. In association with previous 
evidence showing defects in Treg cell activity in SLE, the 
authors have suggested the impairment of regulatory cell 
functions in this and other autoimmune diseases. 
In the DN (IgG+IgD-CD27-) B population of elderly 
people, the rate of mutations evaluated in the V region of 
IgG genes is dramatically reduced when compared with 
young (Buffa S et al., 2011). The increase of the double 
negative memory B cells in the elderly together with the 
reduced rate of mutation might be due to the disconnected 
generation of these cells from germinal centers, as it has 
been demonstrated that ageing negatively affects the 
germinal center formation in secondary lymphoid tissues 
(William J et al., 2002; Frasca D et al., 2005).  
In literature, naïve and memory B cells have been 
distinguished also by producing different pro- and anti-
inflammatory cytokines. Moreover, naïve B cells produce 
principally anti-inflammatory cytokines, whereas memory B 
cells are the main responsible for pro-inflammatory 
cytokines production (Duddy ME et al., 2004, 2007; Sanz I 
et al., 2007, 2008; Lund FE, 2008). On this regard, the 
different distribution of B cell subpopulations in the elderly 
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and their ability to produce pro- or anti-inflammatory 
cytokines might play a central role in the generation of the 
inflammatory environment typical of age. 
 
Successful Aging 
 
The increase in life expectancy was the most 
characteristic demographic process during the second half of 
the last century. Improved child survival, reduced mortality 
rates and decreasing fertility rates worldwide, is resulting in 
a rapid aging of the world’s population,  particularly marked 
in all the industrialized countries. These result in 
modifications in the types of existing elderly groups, with 
considerable socio-economic implications, which are 
difficult to evaluate, and which will certainly influence the 
evolution of the human society (Golini A, 1997). The 
increase of the human lifespan is not simply due to the 
improved economic and cultural conditions and social/health 
cares, but also to the interaction of these new conditions with 
the genetic variability present in human populations. The 
term ‘‘successful aging’’ has been widely used since 1961, 
when it appeared in the first issue of the journal ‘‘The 
Gerontologist’’ (Havighurst, 1961). In 1998, Rowe & Kahn 
defined the term successful aging as “avoidance of disease 
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and disability, maintenance of high physical and cognitive 
function and sustained engagement in social and productive 
activities”.  
Centenarians may represent the prototypes of successful 
aging, indeed, they have escaped major age-related diseases, 
reaching the extreme limit of human life in good clinical 
condition. In most cases, histories of centenarians reveal 
them to be free of cancer, dementia, diabetes and 
cardiovascular diseases.  The interest in centenarians as a 
model for healthy aging is driven by the desire to identify 
key factors associated with exceptional longevity in humans. 
Centenarians are equipped with well-preserved and efficient 
immunological defense mechanisms, and optimal 
combinations of an appropriate lifestyle and genetic 
background. Looking at immune system, some parameters, 
such as NK cell number and activity, were remarkably 
conserved in centenarians and quite similar to those found in 
young people: NK cells are so considered as “markers  of 
successful aging”. On the other hand centenarians  show a 
decrease of B lymphocytes and naïve T cells, a progressive 
increase of CD28-cytotoxic T cells and the accumulation of 
expanded clones of memory T cells, a shrinkage of the T cell 
repertoire as not successfully aged people. An age-related 
increase in adhesion molecules on the lymphocytes surface 
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and a complex reshaping of the cytokine network was also 
demonstrated  in centenarians (Cossarizza A et al., 1996). 
Unexpectedly, centenarians have high plasma level of IL-6 
that, in combination with CMV positivity, signiﬁcantly 
increased the odds ratio for frailty (Schmaltz HN et al., 
2005). The inflammation is not per se a negative 
phenomenon: it is the response of the immune system to the 
aggression of viruses or bacteria. It is an emergent evidence 
that polymorphic alleles of inflammatory cytokines, 
involved in high cytokine production, are related to 
unsuccessful aging as atherosclerosis and Alzheimer’s 
disease; on the contrary, the  control of the  inflammatory 
status may allow to us better attain successful aging 
(Candore G et al., 2006). It must be mentioned that 
Centenarian studies opened the debate on the choose of “the 
right control” to be used in the experiments. 
Certainly , unlike their parents, centenarian offspring 
(CO) have an appropriate control group, i.e. age-matched 
healthy elderly, who haven’t a familiar history of longevity. 
Centenarian offspring, like their centenarian parents, have 
genetic and functional advantages that predispose them to 
healthy aging and longer survival. Some evidences suggest 
that these longevity advantages are associated with lower 
risk of cardiovascular disease, stroke, myocardial infarction, 
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and diabetes mellitus. The prevalence of other age-related 
diseases, like cancer, dementia, osteoporosis, Parkinson’s 
disease are similar between CO and their controls (Terry DF 
et al., 2004 a,b).  
Focusing on B cell branch of the immune system, 
centenarian offspring don’t show the typical naïve/memory 
shift observed in elderly. Though a decreased B cell count 
was observed both in CO and  in their age-matched controls,  
in the former, naïve B cells (IgD+CD27-) were more 
abundant whereas exhausted memory cells (IgD-CD27-)  
were significantly decreased, looking similar to the young 
(Colonna-Romano et al., 2010). It is well documented that 
the quality and the size of the humoral immune response 
declines with age (Frasca D et al., 2005; Cancro MP, 2007; 
Kumar R et al., 2008; Gibson KL et al., 2009; Dunn-Walters 
DK et al., 2010; Bulati M et al., 2011). This change is 
characterized by lower antibody responses and decreased 
production of high-affinity antibodies. The evaluation of 
IgM secreted in the serum by CO shows that the values are 
within the range of the levels observed in young subjects 
(Colonna-Romano et al., 2010). Taken together these data 
support the hypothesis that centenarian offspring have a 
good bone marrow cell reservoir that give them a big 
advantage both to fight the main age-related diseases and to 
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properly respond against new infections, prolonging their 
life. Alternatively, immunogenetic profile may give this 
result. 
 
An example of unsuccessful aging: 
Alzheimer’s disease 
 
Alzheimer’disease (AD), the most common form of 
dementia among elderly people, is one of the major example 
of unsuccessful aging. Initially, AD manifests itself as a 
progressive dementia characterized by amnesia and other 
cognitive deficits. As the disease progresses, people affected 
show defective instrumental functions mediated by the 
association cortex and they may therefore present aphasia, 
apraxia, up to present interneurological disorders. Anyway, 
diagnosis can be made with firmness only upon brain 
autopsy. Pathological changes in the AD brain, observed by 
post-mortem analysis include neurological loss, extracellular 
amyloid plaques, due to the deposit of amyloid beta peptide, 
and intracellular neurofibrillary tangles, consisting of 
phosphorylated tau-proteins. APP molecule, amyloid beta 
peptide precursor, is a transmembrane glycoprotein 
expressed in a ubiquitous way that, once synthesized in the 
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endoplasmatic reticulum, plays an important role for 
neuronal growth, dendritic extension and synapse formation 
(Priller C et al., 2006). The physiological pathway involves 
the α-secretase enzyme which cuts within the APP domain, 
generating two fragments, P3 and AICD, two γ-secretase 
substrates; the pathogenic or amyloidogenic pathway is due 
to the consecutive action of β and γ secretases, catalyzing the 
release of Aβ40 and Aβ42 fragments that will settle, joining 
into plaques.  
The disease occurs predominantly after the age of sixty, 
although there are rarer cases of onset between thirty-fifty 
years. It’s possible to make a distinction between sporadic 
and familial AD.  Most cases of Alzheimer’s disease are not 
hereditary. However, there is a small subset of cases that 
have an earlier age of onset and have a strong genetic 
element. To date, mutations on APP, Presenilin-1 (PS1) and 
Presenilin-2 (PS2), enzymes/cofactors involved in the APP 
digestion, lead to a preferential production of Aβ42, the 
toxic fragment, compared to the not toxic fragment Aβ40 
(Bird TD, 2005). In addition, other genes have been 
identified (e.g. Apolipoprotein E gene ε4 allele) that increase 
the risk of disease. Some studies have shown that cholesterol 
may influence APP degradation pathway inhibiting  α-
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secretase activity but enhancing β- and γ-secretase functions 
(Crestini A et al., 2006; Grimm MO et al., 2011). 
Age is the major risk factor in Alzheimer’s disease. 
Indeed, during aging, brain is massively exposed to a great 
variety of stressors, such as trauma, oxidative stress, tissues 
damages, inflammation, which may be correlated with the 
beginning of the neurodegeneration. The female gender 
could be another risk factor, regardless of the greater 
longevity of women: over eighty years, women’s risk of 
developing AD is 20-30% higher than in males. 
Furthermore, high levels of homocysteine may be related 
with the onset of AD. The causes of hyper-homocysteinemia 
include genetic enzyme defects and acquired conditions, 
quite frequent in the elderly, such as vitamin deficiency that 
altered the methylation process. These conditions can 
promote the development of dementia through endothelial 
modifications, oxidative stress, neurotoxicity and neuronal 
apoptosis. It has been shown that Aβ peptide is able to 
stimulate the synthesis and secretion of IL-1, IL-6 and IL-8 
by microglial cells, activating the inflammatory response. In 
the nervous tissue, these cytokines induce APP and, as 
consequence, Aβ synthesis that, in turn, will increase 
cytokines production by glial cells and neurons. If the 
activation of cells persists and becomes chronic, these 
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cytokines contribute to neurodegeneration (Akiyama H et 
al., 2000). Moreover, the combined action of TNF-α and 
IFN-γ not only stimulates Aβ42 synthesis, but leads to 
reduced secretion of soluble APP protein, generally 
considered as a protein with neuroprotective attitudes.   
Inflammation induced by the accumulation of Aβ peptide 
is not a local phenomenon that concerns only the brain of 
AD patients, but a systemic process  that affects the entire 
organism (Britschgi M et al., 2007).  Different studies have 
shown an increase in chemokine production, like MIP-1α, 
RANTES and MCP-1 by PBMC of AD patients and the 
expression of CCR5 on brain endothelial cells (Li M et al., 
2009; Reale et al., 2008). The expression of CCR2 and 
CCR5 on T cells and CCR5 on B cells on AD patients are 
increased after in vitro stimulation with r-Aβ peptide 
(Pellicanò M et al., 2010).                            
Patients suffering from Alzheimer’s disease show 
systemic changes at the immunological level. An evident 
decrease of B and T cell numbers it has been demonstrated, 
while the number of natural killer doesn’t change (Richartz-
Salzburger et al., 2007). Looking at T cell branch, major 
changes were seen within CD4+ compartment, where AD 
patients show a significant reduction of naïve 
(CD45RA+CCR7+) and a contemporary increase of effector 
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memory (CD45RA-CCR7-) and TEMRA (CD45RA+CCR7-
) T cells, when compared to age-matched controls (Larbi A 
et al., 2009). In our recent paper we have seen a higher 
frequency of activated T cells (CD4+CD25+FoxP3-) in AD 
patients compared to old controls (Pellicanò M et al., 2011). 
 
 
OUTLINE OF THE THESIS  
 
The gradual increase in life expectancy, already observed 
from the last century, has had a great appeal to the scientific 
community that concentrated its efforts trying to understand 
the mechanisms that could lead to longevity.  
Aging is a natural process that occurs in all cells, tissues 
and organs. It is modulated by both genetic and 
environmental factors. One of the most important 
characteristic of aging is the progressive deregulation of 
immune responses, resulting in an increased susceptibility to 
infectious diseases and pathological conditions relating to 
inflammation and  the onset of autoimmune diseases. The 
modifications of the immune system in the elderly, known as 
“immunosenescence”, is a complex process that involves 
both the innate and adaptive immune compartment. Lifelong 
and chronic antigenic load are the major driving force of 
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immunosenescence. The characteristic consequence of aging 
is the progressive filling of the immunological system by 
activated lymphocytes in response to chronic/continuous 
stressor agents. The constant decline in the number of naive 
T cells, the reduction of new B cell precursors, the extended 
survival of memory B and T cells, the increase in 
homeostatic proliferation and clonal expansion, contribute to 
the limited repertoire and the collapse of cell diversity that is 
frequently correlated with poor health status . 
Anyway, some people reach the extreme limit of human 
life in good clinical condition, escaping major age-related 
diseases. Centenarians may represent the prototypes of 
successful aging. Centenarian studies pose the challenge of 
whom to use as control. Unlike their parents, centenarian 
offspring (CO) have an appropriate control group, i.e. 
common elderly, who haven’t a familiar history of longevity. 
Centenarian offspring have a genetic background that could 
predispose them to healthy aging and longer survival.  
The aim of this thesis is to study the immunological 
profile of elderly people and a group of people genetically 
advantaged for longevity (CO), to evaluate if it exists a 
correlation between their genetic advantage and the immune 
system, focusing our attention in particular to the B cell 
branch.  
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Moreover we have also focused our attention on the T 
cell branch of  patient affected by Alzheimer’s disease (a 
model of unsuccessful aging).  Recent studies have shown as 
inflammation  induced by the accumulation of Aβ peptide is 
not a local phenomenon that concerns only the brain of AD 
patients, but a systemic process  that affects the entire 
organism (Britschgi M et al., 2007). In this thesis we will 
also show the results of our study about the immunological 
changes related to AD, analyzing the T cell branch in 
patients compared to healthy age-matched and young 
controls. 
In chapter 2 we present a short report about the 
modifications of the immune system with age 
(immunosenenscence). We focus on the impact of CMV 
infection and we discuss about IRP. Moreover, we analyze B 
cell branch and the collapse of diversity in old age. 
In chapter 3 we compare some B cell parameters 
between centenarian offspring and their age-matched 
controls to evaluate whether any differences exists that could 
be related with the increase lifespan expectancy of people 
genetically advantaged for longevity. 
In chapter 4 we examine the systemic signs of immune-
inflammatory response in AD. We analyze lymphocyte 
subsets and activation markers after in vitro activation of 
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PBMC of AD patients with rAβ42. Moreover, we evaluate 
the production of cytokines and chemokines after in vitro 
activation.  We compare all the data with those obtained by 
age-matched controls.   
In chapter 5 we present a review that show the current 
knowledge about B cell immunosenescence focusing our 
attention on memory B cells and a particular subset, 
IgG
+
IgD
-
CD27
-
, that we have demonstrated is increased in 
healthy elderly. 
In chapter 6 we analyze the modifications of 
naïve/memory B cell compartment in the elderly, evaluating 
also the production of pro- and anti-inflammatory cytokines 
after in vitro activation with different stimuli. In addition, we 
study the somatic hypermutation on memory B cell subsets. 
In chapter 7 we analyze the T cell branch of AD patients 
comparing results with those obtained by the analysis of 
their age-matched controls. In particular, the greatest 
differences were observed in the CD4
+
 rather than the CD8
+
 
T cell compartment. 
In chapter 8 we show a different distribution of 
naïve/memory B cell subsets in the elderly and in 
centenarian offspring. We also characterize a novel 
population of late memory B cells and perform functional 
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analysis to evaluate cytokines production induced by in vitro 
activation with CpG/PMA/Ionomycin. 
Finally, in chapter 9, a summary and general discussion 
of the results are presented. 
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Abstract 
 
The development of the B cell branch undergoes significant 
modifications with age.   Elderly people are characterized by the 
impairment of the B cell response that reflects the inability to 
effectively respond against viruses and bacteria. The 
modifications of the immune system with age 
(immunosenescence) are widely studied in centenarians who are 
considered the main example of successful aging. In the recent 
years, attention has shifted to the centenarian offspring (CO), as 
a model of people genetically advantaged for health aging and 
longevity. In this study, we show the preliminary 
characterization of a new population of late memory B cells, 
CD19
+
CD38
-
CD24
-
, that we describe increased in the elderly 
and contemporary decreased in CO when compared with healthy 
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age-matched controls (AM). Here, we demonstrate that human 
CD19
+
CD38
-
CD24
-
 is involved in TNF production. We 
hypothesize that the expansion of these cells, also negative both 
for IgD and CD27, might be related to the inflammatory status 
of elderly people as the result of a time-enduring stimulation of 
the immune system.  In addition, we evaluate the expression of 
RP105 (CD180), the toll-like receptor (TLR) associate 
molecule, expressed on  B cells. In this paper We describe an 
age-related increase of RP105-negative B cells in peripheral 
blood of elderly people and its up-regulation in memory B cell 
subsets. In this paper we discuss the modified expression of 
CD180 and its potentially role as marker of immunosenescence. 
 
Introduction  
 
B cells are key mediators of immunity. The humoral immune 
response, due to the B cell compartment activation, involves a 
response to pathogens by producing antibodies to neutralize 
bacteria and viruses, secreting cytokines and interacting with 
other components of the immune system. The early step of  B 
cell development occurs in the bone marrow from hematopoietic 
stem cells (HSC). The early progenitors of B lymphocytes 
develop into pro- , pre- and immature B cells [1,2], after 
subsequently stages of differentiation that involve light and 
heavy chain genes rearranging and the expression of cell surface 
markers. When immature B cells become independent from 
stromal factors, they leave the bone marrow via the blood stream 
as transitional B cells, [3-6], up to secondary lymphoid organs. 
Only a small fraction of immature B cells become mature naïve. 
Therefore, transitional B cells are considered as a negative 
selection checkpoint for autoreactive B cells [5,7]. Transitional 
B cells have been widely studied in mice [8,9]. As in the mouse, 
human transitional B cells can be found in the bone marrow 
(BM), peripheral blood (PB) and spleen [7]. The absence of 
ABCB1 transporter activity  has been used to distinguish 
transitional B cells from mature naïve B cells [10]. In human 
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peripheral blood, naïve and memory B cells have been described 
on the basis of the differential expression of IgD and CD27 [11-
14]; naïve B cells have been identified as IgD
+
CD27
-
, whereas 
the expression of CD27 allowed to distinguish memory B cells 
subsets: IgD
+
CD27
+
 , indicated as unswitched memory B cells 
or marginal zone-like B cells [15], IgD
-
CD27
+
 as classical 
switched B cells. Afterwards, a population of DN B cells (IgD
-
CD27
-
) has been identified too [16,17]. The IgD
-
CD27
+
 
population has not been further subdivided. As a consequence, 
this is a mixed population of IgM
+
 and Ig class-switched 
memory B cells [12,18,19]. In addition, the complexity of the 
memory B cell pool has been demonstrated by the evidence of a 
IgM memory B cell population identified as IgM
+
IgD
+
CD27
+
 
and of the “IgM only” memory B cells identified as  IgD- 
IgM
+
CD27
+
. IgM
+
CD27
+
IgD
+
 and IgM
+
CD27
+
IgD
-
 have not 
always been distinguished each  other. The former, known as 
“natural effector B cells”, have reduced replication history and 
SHM levels compared with the latter. So,  they seem to be a 
mixed population of GC-derived and splenic marginal zone-
derived memory B cells [18]. On the contrary, IgM-only 
memory B cells appear to be generated from germinal center 
responses,  [16,18,20]. In these last years, a different flow 
cytometric approach has been used to distinguish naïve from 
memory B cells [7-9]. The use of two developmentally regulated 
markers, CD24 and CD38, in association to the B-lineage 
marker CD19, allowed to identify  three different B cell 
populations: CD19
+
CD38
high
CD24
high
, a population of 
transitional B cells that includes immature B cells, 
CD19
+
CD38
int
CD24
int
 defined as mature B cells, and 
CD19
+
CD38
-
CD24
high
 called “primarily memory B cells”. In a 
recent paper [21], the authors have shown as the stimulation 
with CD180 (RP105), an homologous of TLR4 that regulates 
TLR4 signaling, has been able to induce intrinsic B cell 
proliferation and differentiation from transitional to mature B 
cells. The expression of RP105 surface marker has been also 
evaluated on peripheral blood B cells from patients with 
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different autoimmune diseases. The number of RP105-negative 
B cells has been shown increased in SLE patients compared 
with normal subjects [22]. It was hypothesized that RP105 may 
regulate B cell activation and that RP105-negative B cells might 
be involved in the production of autoantibodies and take part in 
pathophysiology of SLE.   
 The number of total B cells and the composition of the B 
cell subsets shows age-dependent changes[23].  The frequency 
of transitional B cells as well as naïve B cells decreases rapidly 
during the first years of life, while the frequency of switched 
and unswitched memory B cells increases. After these changes 
the absolute number of B cells remains stable while the shift 
from naïve to memory continues  [24]. In elderly people 
IgD
+
CD27
-
 naïve B cells result significantly reduced [25,26]. On 
the other hand, DN B cells (IgD
-
CD27
-
) are significantly 
increased in the elderly [17,27]. Different studies have shown 
that the same population is expanded in patients suffering by the 
chronic stimulation of the immune system, such as SLE [13], 
HIV [28] and in healthy subjects challenged with RSV [29]. The 
evaluation of the processes involved in the modifications of the 
immune system in the elderly (immunosenescence) led to 
consider the immunological features of those subjects 
predisposed to longevity. Centenarians have been widely studied 
in order to identify key factors associated with exceptional 
longevity in humans. However, centenarian studies posed the 
challenge of whom to use as control. Unlike their parents, 
centenarian offspring (CO) have an appropriate control group, 
i.e. common elderly, who haven’t a familiar history of longevity. 
In these years, we and other groups have focused our attention 
on the study of centenarian offspring, trying to evaluate any 
possible correlation between their genetic background, predictor 
of longevity, and their immunological profile. CO don’t show 
the typical naïve/memory shift observed in elderly. In particular, 
we have not seen the increase of DN (IgD
-
CD27
-
) B cells. Also 
the evaluation of IgM secreted in the serum by CO has shown 
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that the detected values are within the range of the levels 
observed in young subjects [27].  
Several distinct memory B cells have been identified in 
humans, although the association between their specific 
phenotype profile and function remains to be further clarify. In 
this study, we show the preliminary characterization of a new 
population of late memory B cells, CD19
+
CD38
-
CD24
-
, 
performing analysis in order to understand its biological role and 
function. Moreover, as we are interested in the modification of 
the immune system during aging, we carried out comparative 
studies using B cells from elderly people. Indeed, data from 
literature show how in the periphery of elderly people, the 
extended survival of memory B cells and the clonal expansion 
contribute to the limited repertoire and the collapse in B cell 
diversity that is correlated with poor health status and the 
impairment of antibody response [30-36]. We have  extended 
our analysis to centenarian offspring (CO) that, like their 
centenarian parents, have genetic and functional advantages that 
predispose them to healthy aging and longer survival, with the 
purpose to evaluate the immunological features that may be 
related with their healthiness. Moreover, we have examined the 
expression of CD180 on total B cells and CD38/CD24 B cell 
subsets, in order to evaluate the age-related modulation of this 
marker. 
 
Material and Methods 
 
Subjects 
12 healthy Sicilian Centenarian Offspring ( age range: 70.1 ± 
8.3) with almost one of their parents centenarian  (≥ 100 years) 
have been investigated. A total of  8 young (age range: 28.5 ± 
1.9), 8 Old (age range: 86.4 ± 3.8),  and 7 Age-Matched 
Controls  (age range: 69.1 ± 9) were also included in the study. 
All subjects were in good health according to their clinical 
history and none of the them had neoplastic, infectious, 
autoimmune diseases, or received any medications influencing 
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immune function at the time of the study. The controls were 
collected from the same population as the patient cohort. The 
study received approval from local ethic committee and all 
participants gave their informed consent. 
Whole blood was collected by venepuncture in vacutainer tubes 
containing ethylenediaminetetraacetic acid (EDTA). Peripheral 
blood mononuclear cells (PBMC) were isolated by density 
gradient centrifugation on Ficoll-Lympholyte (Cedarlane 
Laboratories Limited, Ontario, Canada) and stored frozen. 
 
Flow cytometry 
1. Phenotype analysis 
To characterize the phenotype of B lymphocyte subsets, 
extracellular labeling was performed with anti-CD19-PE, CD24-
Pe-Cy7, CD5-V450, IgD-FITC, IgG-APC-H7, IgM-PerCP-
Cy5.5 (BD Biosciences), CD27-Qdot605 (Invitrogen), CD80-
PerCP (Abcam), CD38-eFluor650 (eBioscience) and 
intracellular staining with anti-FoxP3-AlexaFluor647 (BD 
Biosciences).  
 
 
2. Stimulation of PBMC with CpG/phorbol myristate acetate 
(PMA)/ionomycin for B cell IL-10, IL-6, TNF production 
PBMC (10
6
 cells/ml) were suspended in EX VIVO medium with 
or without CpG-B 2006 (3 µg/ml, Tib Molbiol), PMA (50 
ng/ml), ionomycin (1 mg/ml) and monensin sodium salt (2 mM, 
SIGMA ALDRICH) in 24-well flat-bottom plates for 5h, at 
37°C (CO2 5%). Cells were harvested, washed and directly 
stained with anti-CD19-PerCP-Cy5.5, CD24-Pe-Cy7, IgD-
FITC, IgG-APC-H7, CD180-PE (BD Biosciences), CD27-
Qdot605 (Invitrogen), CD80-PerCP (Abcam), CD38-eFluor650 
(eBioscience). For indirect immunofluorescence, anti-human 
CD5 (clone UCHT2) culture supernatant hybridoma cell line 
(Zentrum für Medizinische Forschung, Tübingen, Germany), 
was used as primary antibody. The secondary antibody was rat 
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anti-mouse PO (Invitrogen). Citofix&Citoperm (BD 
Biosciences) was used. Finally cells were stained with anti-IL-
10-APC (Miltenyi Biotec), TNF-AlexaFluor700 and IL-6-V450 
(BD Biosciences), washed and analyzed. 
 Cell viability was determined with RedVid (Invitrogen). 
All staining steps were performed in PFEA buffer (PBS, 2% 
FCS, 2 mM EDTA and 0.01% Na Azide). Blocking of non-
specific binding sites was accomplished using human 
immunoglobulin GAMUNEX (Bayer, Leverkusen, Germany) or 
mouse serum (Caltag/Invitrogen, Karlsruhe, Germany). For each 
experiment, cells or mouse/rat κ-chain Comp Beads (Becton 
Dickinson) were stained with the corresponding fluorochrome-
labeled antibodies and incubated for 20 minutes at 4°C in the 
dark. Human unstained cells were used as negative controls. 
After washing with PFEA, the cells or beads were re-suspended 
and measured using LSR-II flow cytometer and the acquisition 
software FACSDIVA (Becton Dickinson). Data were analyzed 
using FlowJo software (Tree Star, Portland, OR). For data 
analysis, dead cells (RedVid-positive), were excluded. CD19
+ 
living cells were gated within the SSC/FSC lymphocyte gate. 
 
3. Cytokine Detection 
For analysis of cytokine production, serum samples from 
patients were tested with Cytometric Bead Array (CBA) Human 
Multiflex System (Becton Dickinson).The CBA was used 
according to the manufacturers’ protocol (Becton Dickinson, 
Oxford, UK). Two-color flow cytometric analysis was 
performed using a flow cytometer LSR-II. Analysis was made 
using CBA dedicated analysis software, “FCAP Array™ 
software”, to generate results in graphical and tabular format. 
 
 
 
Statistical Analysis 
All statistical analysis were performed with Graph-Pad Prism 
4.0 using the Mann-Whitney nonparametric U test to compare 
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two independent groups. Statistical significance was expressed 
as * P < .05, ** P <.01, *** P < .001 and it is also shown in the 
figures. All values are expressed as mean ± SEM. 
 
RESULTS 
 
Characterization of CD38 +-/CD24+- B cells subsets 
 
Analysis of B lymphocytes from our samples, carried out by 
using CD38 and CD24 markers, allowed us to discriminate four 
distinct populations: CD19
+
CD38
hi
CD24
hi 
(classical 
transitional), CD19
+
CD38
int
CD24
int (“mature naïve”), 
CD19
+
CD38
-
CD24
+(“primarily memory )  and CD19+CD38-
CD24
- 
(Fig. 1a). Afterwards, we evaluated the expression of IgD 
and CD27 on the four B cell subpopulations above identified. 
On the basis of their functional organization into the different 
naïve/memory B cell subsets, we observed as 
CD19
+
CD38
hi
CD24
hi 
and CD19
+
CD38
int
CD24
int
   show a  naïve 
phenotype (IgD+CD27-). The CD19
+
CD38
-
CD24
+ 
B 
lymphocytes, just called primarily memory B cells, begin to 
express CD27 and contemporary loss IgD (IgD
+
CD27
+
/IgD
-
CD27
+
). The analysis of the CD19
+
CD38
-
CD24
-
 B cell subset 
indicates that these cells are predominantly IgD- (IgD
-
CD27
+
/IgD
-
CD27
-
) (Fig. 1b). In order to deeply characterize 
these populations we have evaluated the expression of different 
immunological markers: IgD, IgM, CD27, CD5, CD80 and 
CD180. Further phenotipical identification revealed as the 
largest part of CD19
+
CD38
hi
CD24
hi 
are IgD
hi
, IgM
hi
, CD27
-
, 
CD5
+
, CD80
hi
, CD180
hi
; CD19
+
CD38
int
CD24
int 
are IgD
hi
, IgM
int
, 
CD27
-
, CD5
-
, CD80
-
, CD180
hi
; CD19
+
CD38
-
CD24
+
 are IgD
int
, 
IgM
hi
, CD27
hi
, CD5
-
, CD80
int
, CD180
hi
; finally, CD19
+
CD38
-
CD24
- 
are classified as IgD
-
, IgM
-
, CD27
int
, CD5
hi
, CD80
-
, 
CD180
- 
(Table 1). The table shows the percentage of positive 
cells of a representative experiment. 
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Age-related changes on B cell branch show a different 
distribution of naïve/memory subsets 
 
To determine whether aging shapes the distribution of 
peripheral immune cell subsets, we investigated the B cell 
branch of a cohort of young and elderly people. Moreover, in 
order to assess if centenarian offspring, who are enriched for 
longevity, displayed a different immune profile, we compared 
data with those obtained by the study of age-matched control 
group. We performed a comparative analysis of these four 
subpopulations, evaluating their distribution in our different age 
groups. We did not observe any significant difference for 
CD19
+
CD38
hi
CD24
hi 
and CD19
+
CD38
int
CD24
int 
(data not 
shown). Concerning CD19
+
CD38
-
CD24
+
, we observe a trend of 
age-related increase. Interestingly the amount of these cells in 
CO is more similar to that observed in young donors than in 
their age-matched controls (Fig. 2a). Moreover, CD19
+
CD38
-
CD24
-
 B cells showed an highly significant age-related increase. 
So, concerning these lymphocyte subsets, centenarian offspring 
behave in the middle between young and elderly (Fig.2b). 
 
Age-related changes  of IgM
+
CD27
-
 (naïve mature), 
IgD
+
IgM
+
CD27
+
 (natural effector), and IgD
-
IgM
+
CD27
+
 (IgM-
only) B cell subsets. 
 
The complexity of the memory B cell pool has been further 
demonstrated by the evidence of different IgM
+
 B cell subsets. 
According to a recent gating strategy based on CD38/CD24 
expression within CD19
+
 B cell compartment, CD38
dim
CD24
dim 
were separated into three B cell populations: IgM
+
CD27
- 
(naïve 
mature), IgD
+
IgM
+
CD27
+
 (natural effector) and IgD
-
IgM
+
CD27
+
 (IgM-only) (Fig.3a) [21].  The comparative study 
between our four groups of subjects revealed a different 
distribution of B cells identified on the basis of these markers 
between young and old donors. Besides,  centenarian offspring 
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show a youth  immune profile when compared with age-
matched controls. Indeed, the percentage of IgM
+
CD27
-
 (naïve 
mature) (Fig 3b) is significantly increased  in the group of 
people genetically advantaged for longevity. The analysis of the 
other two IgM
+
CD27
+
 memory B cell subsets showed a 
significantly age-related reduction (fig 3c, d).  
 
CpG + PMA/Ionomycin stimulation induce intracellular 
cytokine production by human blood B cells in vitro 
 
To study the functional properties of peripheral blood B 
lymphocytes, we tested their ability to produce cytokines under 
“in vitro” combined action of CpG/PMA/Ionomycin. We 
evaluated the production of IL-10, IL-6 and TNF by 
CD38/CD24 B cell subsets. Our analysis revealed that 5h after 
this “strong” stimulation, the main IL-10 producing cells 
resulted CD19
+
CD38
hi
CD24
hi
 (Table 2a). CD19
+
CD38
-
CD24
+
 
and CD19
+
CD38
-
CD24
- 
resulted the more responsive B cell 
populations for TNF production (Table 2b). On the other hand, 
this kind of stimulation was not able to induce IL-6 production. 
Indeed, we did not detect a significant increase in production of 
IL-6 compared to unstimulated PBMC (not shown).  
We analyzed the levels of IL-10 produced by 
CD19
+
CD38
hi
CD24
hi
   comparing the different groups. Our 
analysis revealed a not significant age-related increase (not 
shown). Afterwards, we compared the two major B cell 
subpopulations involved in the TNF production.  We did not 
detect any differences comparing the different groups (Table 
2b).  
 
Cytokines detection in the  serum 
 
We next evaluated any possible correlation between the level of 
cytokines detected after “in vitro” stimulation and basal levels 
observed in the serum of patients. For this purpose we 
performed the high sensitive assay  CBA human multiflex 
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system in order to evaluate IL-10 and TNF  production. In the 
present study, serum levels of IL-10 in the young resulted to be 
three to four time higher than  those of elderly people (Fig. 4). 
Concerning TNF levels detected in the serum of patients, our 
preliminary data underlined individual differences that didn’t 
allow us to perform a statistical analysis (data not shown). 
 
RP105-negative B cells and its expression on IgD/CD27 B cell 
subsets  
 
As the lack on B cells of the TLR4-homologous CD180 has 
been described in chronically stimulated SLE patients, we 
analyzed the percentage of CD19
+
CD180
-
 B lymphocytes 
obtained by peripheral blood of young, elderly, centenarian 
offspring (CO) and their age-matched controls (AM). In Fig.5a 
we report a significant increase of this population in the elderly 
when compared with young. No differences were obtained by 
the comparative analysis of CO and their controls although, the 
percentage of CD180- B cells in CO and AM controls is 
increased and decreased when compared respectively to that 
observed in young and old donors .  Afterwards, we evaluated 
the presence of CD180 on cell subsets identified on the basis of 
the expression of IgD and CD27.  Interestingly, the analysis of 
IgD
-
CD27
-
 (DN) B cells revealed that these cells are for the 
most part negative for CD180, whereas  the other  populations 
are  CD180
+
  (Fig. 5b). 
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Fig. 1. (a) Gating strategy to identify 4 CD38/CD24 B cell subsets:  
CD19
+
CD38
hi
CD24
hi
 (upper right), CD19
+
CD38
int
CD24
int 
(the region in the 
middle), CD19
+
CD38
-
CD24
+
(upper left), and CD19
+
CD38
-
CD24
- 
(lower 
left). (b) Characterization of CD38/CD24 B cell subsets according to 
IgD/CD27 organization into 4 naïve-memory compartments. This 
phenotypical identification confirmed that the majority of 
CD19
+
CD38
hi
CD24
hi 
and CD19
+
CD38
int
CD24
int
 are naïve (IgD
+
CD27
-
), 
while CD19
+
CD38
-
CD24
+
 begun to express a memory profile: some of them 
appear memory unswitched (IgD
+
CD27
+
), others memory switched (IgD
-
CD27
+
). Moreover, CD19
+
CD38
-
CD24
- 
B cell subset, principally IgD
-
, show 
features of late memory B cells (IgD
-
CD27).   
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 Percentage of Positive cells 
*(MFI) 
Markers CD19
+
CD38
hi
C
D24
hi
 
CD19
+
CD38
int
CD
24
int
 
CD19
+
CD
38
-
CD24
+
 
CD19
+
CD
38
-
CD24
-
 
IgD 86.2 82 48.4 12.3 
CD27 8.4 14.2 68.8 51 
IgM 51.3 30.1 45.8 8.1 
CD5 21.3 8.5 6.4 47.2 
*CD80 698 272 396 141 
CD180 93.3 89.4 94.8 4.1 
 
Table 1. A typical experiment showing the expression of IgD, CD27, 
IgM, CD5, CD80, CD180 on CD19
+
CD38
hi
CD24
hi
, 
CD19
+
CD38
int
CD24
int
, CD19
+
CD38
-
CD24
+
, CD19
+
CD38
-
CD24
-
 B 
cell subsets. Results, expressed as percentage of positive cells (CD80 
as MFI), are representative of all subjects analyzed. 
 
 
 
Fig. 2a (Left). Trend of increase age-related of CD19
+
CD38
-
CD24
+
 B cell 
subset. B (Right). Significant increase of CD19
+
CD38
-
CD24
-
 B cell subset in 
elderly people (Old and AM) when compared to young. CO, like young, 
show a lower percentage of this population when compared to their age-
matched controls. 
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Fig. 3. (a) Diversity in the human B cell compartment and peculiar 
distribution in young and old, centenarian offspring (CO) and their age-
matched (AM) controls. Within the CD19
+
 B cell compartment, B 
lymphocytes are organized on the basis of CD38 and CD24 expression. 
According to Berkowska’s gating strategy [21], CD38dimCD24dim B 
lymphocytes were subdivided on the basis of IgM, CD27 and IgD expression, 
defining IgM
+
CD27
-
 naïve mature, IgD
+
IgM
+
CD27
+
 natural effector and IgD
-
IgM
+
CD27
+
 IgM-only. (b) A direct comparison between CO and AM 
underline as the former show a significantly higher percentage of naïve 
mature. (c) A substantial and significant age-related decrease was observed in 
the natural effector subset. (d) Moreover, elderly people display a decrease of 
IgM-only subset when compared with young such as CO exhibit higher level 
of the same population respect their AM controls.   
 
 
 
 
 
 
 
 
 
 
 
 
   
112 
 
(a) 
IL-10 
Subsets Young Old CO AM 
CD38
hi
CD24
hi
 917.4±310.
5 
2916.5±892.
9 
2059.3±277.
8 
2575.2±484.
6 
CD38
int
CD24
i
nt
 
316.4±37.1 2017.2±947.
5 
1066.8±427.
2 
924.2±523.7 
CD38
-
CD24
+
 541.4±136.
5 
1137.7±106.
9 
780.7±111 746.5±157.9 
CD38
-
CD24
-
 248.4±37.7 869±401.9 688.2±232.4 479±233.8 
 
(b) 
TNF 
Subsets Young Old CO AM 
CD38
hi
CD24
hi
 194.4±39.4 380.5±67.1 317.5±45.1 313±20.4 
CD38
int
CD24
int
 497.6±129 326.7±30.1 355.3±87.1 142.1±56.4 
CD38
-
CD24
+
 881.6±176.2 453.7±65.1 605.3±122.9 265±112.4 
CD38
-
CD24
-
 700.3±300.9 743.7±226.6 809.7±391 268±122 
 
Table 2. Evaluation of IL-10 and TNF production by CD38/CD24 B cell 
subsets after CpG/PMA/Ionomycin stimulation. (a) CD19
+
CD38
hi
CD24
hi 
is 
the main B cell subsets involved in IL-10 production. An age-related trend of 
increase was observed after 5h of stimulation. In the table 2(b) it is shown as 
the major contribute on the production of TNF is given by  CD38
-
CD24
+ 
and 
CD38
-
CD24
-
. No significant differences have been observed between the 
four groups analyzed. All the data are expressed as MFI (Mean ± SEM) and 
they are representative of 5 young, 4 elderly, 6 centenarian offspring and 4 
age-matched controls. 
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Fig.4. IL-10 detection in the serum of patients with cytometric bead array 
(CBA) human multiflex system (Becton Dickinson). Our analysis have 
revealed an higher concentration in young subjects compared with old 
people. No differences between centenarian offspring (CO) and age-matched 
(AM) was observed.  
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(a) 
 
 
 
Fig. 5 (a) Evaluation of CD19
+
CD180 (RP105)
- 
B cell population among the 
different age related groups analyzed. Old people show a significantly 
increase in percentage of the B cell subset, that lack CD180 expression 
marker, when compared with young. (p = 0.01). Histograms are 
representative of all subjects included in the study. Bar graphs indicate mean 
± SEM. (b) Representative dot plots showing CD180
 
modulation among  
naïve/memory B cell compartments identified by the expression of IgD and 
CD27. A progressive down-regulation of the expression marker from naïve 
(IgD
+
CD27
-
) towards DN (IgD
-
CD27
-
) is demonstrated. 
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BRIEF DISCUSSION 
 
A typical feature of ageing is a pro-inflammatory status which is 
related to many age-related diseases (as cardiovascular, 
Alzheimer disease,). The increased health risk in old age is the 
result of a combined action of  environmental stressors, that 
accumulate over time, and the individual genetic background. 
Besides, not all subjects or population groups are equally 
susceptible to the effects of the time-enduring stimulation of the 
immune system. It is known that in the elderly, there is an 
impairment of both innate and adaptive immune response that 
renders them less able to respond to new infectious agents and to 
vaccines [30-36]. On the other hand, recently evidences have 
shown a well preserved  immune profile of a group of healthy 
elderly centenarian offspring (CO) who seem to have genetic 
and functional advantages associated with the reduced risk of 
disability with age [17, 38].   
The B cell lineage in aging, undergoes dramatic 
alterations in the cellular composition. In these last years, 
several new B cell populations have been described although 
their phenotype  has not been always associated with  biological 
function. In the present work, we have characterized age-related 
changes in distinct peripheral B cell populations.  
According to the gating strategy proposed by Carsetti et 
al., 2004, our results have shown four distinct B cell 
populations: CD19
+
CD38
hi
CD24
hi 
(classical transitional), 
CD19
+
CD38
int
CD24
int (“mature naïve”), CD19+CD38-CD24+ 
(“primarily memory”)   and  the never described CD19+CD38-
CD24
- 
. We have confirmed data from literature that affirms that   
CD19
+
CD38
hi
CD24
hi
, transitional B cells, have a regulatory 
function, as this population produce a large amount of IL-10 
(Breg) [37].  Previous study have reported that the frequency of 
transitional B cells is rapidly reduced  during the first years of 
life, to stabilize after 5 years of age [24]. Here, we observed no 
related changes with old age of this population. Interestingly,  
elderly people produce more IL-10 than young people after a 
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“strong” stimulation with CpG/PMA/Ionomycin. Probably, the 
increase in the production of this cytokine could be a 
mechanism of compensation of the typical  pro-inflammatory 
status of elderly people. This observation is corroborated by the 
increase of the percentage of CD19
+
CD38
hi
CD24
hi  
IL-10 
producing cells in SLE patients [37]. Alternatively, in elderly 
people these cells are not the main source of IL-10. In our 
previous paper, we have described that both in young and 
elderly donors the physiological  (α-CD40 and IL-4) stimulation 
of B cells induces a good IL-10 production by unswitched 
(IgD
+
CD27
+
) memory B cells. This kind of stimulation  was 
also able to stimulate naïve (IgD+CD27-) B cells of elderly 
people to produce IL-10. Moreover, we observed that the 
“strong” stimulation (CpG/PMA/Ionomycin) induced both naïve 
and unswitched B cells of young donors to produce the anti-
inflammatory cytokine. All the data suggest that naïve B cells 
from young donors need an adequate stimulus to be activated 
“in vitro”. On the other hand, we believe that elderly people 
produce higher level of IL-10, maybe because they are basally 
activated by bacteria or viruses. So, another hypothesis could be 
related to the kind of the stimulus. It is also possible that any B 
cell might have the capacity to produce IL-10 if activated 
appropriately.    
In this work, we have demonstrated for the first time, the 
existence  of a new population of  memory B cells with 
functional capacity. We have shown an age-related increase of 
the CD19
+
CD38
-
CD24
- 
 B cells. This B cell subset, as IgD
-
CD27
- 
(DN) B cells, lack the expression of IgM and CD80. 
Interestingly, we have observed that the great part of these cells 
express the marker CD5. We have also observed the ability of 
this population to produce “in vitro” the pro-inflammatory 
cytokine, TNF. We have performed the same analysis in CO and 
their AM controls. Our data show that  CO behave as young 
donors, in fact  they have a similar percentage of this B cell 
subset. We have hypothesized that the age-related increase of 
this population, as it has been previously demonstrated for IgD-
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CD27- B cells [17,27],  might be the result of the time-enduring 
stimulation of the immune system. For this purpose, we have 
assessed the distribution of the two markers, IgD and CD27 on 
the four CD38/CD24 B cells population above described. We 
have confirmed that, CD19
+
CD38
hi
CD24
hi  
and 
CD19
+
CD38
int
CD24
int
 have a naïve phenotype (IgD+CD27-); 
CD19
+
CD38
-
CD24
+
 begin to express CD27 and contemporary 
loss IgD (IgD
+
CD27
+
/IgD
-
CD27
+
). Interestingly, the analysis of 
the CD19
+
CD38
-
CD24
-
 B cell subset indicates that these cells 
are predominantly IgD- (IgD
-
CD27
+
/IgD
-
CD27
-
). This last 
subset could represent a population of late memory B cells. 
Moreover, all this data suggest a modulation of the expression of 
CD38 and CD24 from transitional to late memory 
developmental stage.  
A further evaluation of CO B cell branch was performed 
evaluating the expression of CD27, IgM and IgD. It is in fact 
known that IgM memory B cells (IgD
-
IgM
+
CD27
+, “IgM-only” 
and IgD
+
IgM
+
CD27
+, “Natural effector” B cell cell subsets), are 
reduced in the elderly, so predisposing them to pneumococcal 
infection [12,19]. Here again, we show that CO has a “younger” 
B cell profile. In fact, the percentage of these cells are not 
reduced as their age-matched controls and are more similar to 
the percentage observed in young people. In addition, also the 
population of IgM
+
CD27
-
, called Naïve mature, is significantly 
increased in CO when compared with their controls. 
It is well known that B cells participate in the immune response, 
not only producing antibodies, but also catching the pathogens 
by PRR (pattern recognition receptor) as TLRs. It has been 
recently demonstrated the expression, on murine B cells, of 
RP105 (CD180), the toll-like receptor-   (TLR-)associated 
molecule. It has been shown that B cells from RP105-deficient 
mice were hypo-responsive to TLR-4 and TLR-2 stimulation 
[39,40]. In a recent work, authors have evaluated the expression 
of RP105  on peripheral blood B cells from patients with 
different autoimmune diseases. The number of RP105-negative 
B cells has been shown increased in SLE patients compared 
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with normal subjects [22]. Here, we have evaluated the 
percentage of B cells defective for CD180 expression on  young, 
old, centenarian offspring and age-matched controls. 
Interestingly, we have observed an age-related increase of 
CD19
+
CD180
-
 B cell subset. Afterwards, we have checked the 
expression of CD180 on IgD/CD27 B cell subpopulations, 
observing a down-modulation of this marker from naïve 
(IgD
+
CD27
-
) to DN (IgD
-
CD27
-
) B cells. So, the reduction in 
CD180 expression observed in the elderly and the age-related 
increase of DN B cells, defective for CD180, could be related to 
increased susceptibility to GRAM- infectious diseases of elderly 
people. On the other hand, the amount of CD180-negative B 
cells in the other groups is similar: this result suggest that the 
loss of CD180 is probably an age-related phenomenon. The age 
range of CO is, in fact, 70.1 ± 8.3, whereas age range of old is 
86.4 ± 3.8. We believe that CD180 may regulate B cell 
activation and that RP105-negative B cells might be involved in 
the production of autoantibodies and take part in 
pathophysiology of different autoimmune diseases. Further 
investigations could be necessary to better understand the 
biological role of CD180 that could be used as marker of 
senescence. 
Next, we have evaluated the IL-10 levels detected in the 
serum of the four groups of subjects: we show that only young 
subjects have high levels of IL-10, whereas all the other groups 
(CO, AM and O) show a progressive decrease. This is an 
interesting data, although we have not significant differences 
between CO and AM or O, as CO show a slight higher level of 
this regulatory cytokine. 
In the whole, our data suggest that the B cell branch of 
centenarian offspring behave similar to those observed in young 
subjects. This hypothesis is corroborated by the  reduced 
number of “late memory” B cells and a higher level of IgM B 
cell subsets. These observations could suggest a good bone 
marrow reservoir of centenarian offspring. This apparently 
immunological advantage, could help them both to fight the 
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main age-related diseases and to properly respond to 
vaccinations.  
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Summary and general discussion 
 
 The progressive and cumulative modifications of the 
immune system with age, known as “Immunosenescence” 
(Franceschi C et al., 1995; Pawelec G et al., 2005), have a 
great impact on immune performance in late life, 
contributing to the decreased ability of the elderly to respond 
to new antigens and vaccinations (Grubeck-Loebenstein B et 
al., 2009). The direct consequence of these modifications is 
the increased susceptibility of old people to infectious 
diseases. These changes occur in all leukocytes and 
accordingly, affect innate and adaptive immune functions. 
The acquired compartment of immune systems shows 
significant modifications in the elderly, in fact both T and B 
cell branches are compromises, resulting in a reduction of 
the number of virgin antigen-non experienced cells and, 
simultaneously, filling the immunological space with 
expanded clones of memory and effector, antigen-
experienced cells (Franceschi C et al., 2000; Miller JP, 
Cancro MP, 2007).  
The humoral immune response of elderly people is 
qualitatively and quantitatively diminished  when compared 
with the immune response of young people. The amount of 
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the different Ig isotypes changes with age: in fact, although 
the number of B cells is decreased, it has been described an 
increase of serum concentration of IgG, IgA and, to a lesser 
extent, IgE. On the contrary, both IgM and IgD are 
decreased (Listì F et al., 2006).  
A typical feature of aging is a chronic, low-grade pro-
inflammatory status observed in the old people. In  this 
context, elderly people are characterized by a general 
increase in the production of pro-inflammatory cytokines 
and inflammatory markers (Bruunsgaard H et al., 2003a, b, 
c; Krabbe KS et al., 2004; Fulop T et al., 2006;Cevenini E et 
al., 2010). The consequence of this situation is an age-
dependent up-regulation of the inflammatory response, 
“Inflamm-aging”, that render elderly prone to frailty 
(Balistreri CR et al., 2008; Franceschi C et al., 2005; Lio D 
et al., 2004; Pes et al., 2004). 
Moreover, it has been suggested that chronic antigenic 
stimuli, such as herpes virus infection (e.g. CMV)  appears 
to accelerate immune aging (Pawelec G et al., 2005; Akbar 
AN and Fletcher JM, 2005). The continuous attrition caused 
by chronic antigenic load results in a generation of 
inflammatory responses involved in age-related diseases 
(Pawelec G et al., 2005; Vasto S et al., 2007). 
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A typical pathology, correlated to aging, is Alzheimer’s 
disease (AD), that represents one of the main causes of 
disabilities among elderly people. The sequelae of central 
nervous system (CNS)  inflammation processes, observed in 
the brain of AD patients, may be related primarily to waning 
microglial neuroprotection resulting in aging-related 
neurodegenerative changes (Streit WJ and Xue Q-S, 2010).  
Moreover, changes in lymphocytes distribution and in 
cytokines levels in the plasma of AD patients have been 
identified too (Richartz-Salzburger E et al., 2007; Larbi A et 
al., 2009; Pellicanò M et al., 2011).  
In this scenario, however, centenarians represent a group 
of select survivors who have, at least, markedly delayed 
diseases that normally cause mortality in the general 
population. They are rightly considered an example of 
successful aging, a human model of disease-free or people in 
which the onset of the diseases is delayed (Franceschi C, 
Bonafè M, 2003). In addition, centenarian offspring (CO) 
have a genetic advantage that could predispose them for 
longevity and they are preserved from age-associated 
diseases, in particular cardiovascular diseases, stroke, 
myocardial infarction, and diabetes mellitus (Terry DF et al., 
2004 a,b).   
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The aim of this thesis is to study the changes of the 
immune system with age observing any possible correlation 
between the genetic profile, predictor of longevity, and the 
immunological profile. In this context, we focused our 
attention principally on the naïve/memory B cell 
compartment of centenarian offspring. Concerning, instead, 
the study of the age-related diseases due to the pro-
inflammatory microenvironment typical of the elderly, we 
have analyzed some immune parameters of people with 
Alzheimer’s disease. 
In chapter 2, we did a short report about the mechanisms 
of immunosenescence. We analyzed the modifications of the 
immune system in elderly people and their increased 
susceptibility to infectious diseases and pathological 
conditions relating to inflammation or autoreactivity. We 
discussed about the relationship between chronic CMV 
infection and adverse health outcomes, and the others 
immunological parameters define an immunological risk 
profile (IRP) predicting 2, 4 and 6 years of mortality. We 
also analyzed the modifications of the B cell branch during 
aging and the shrinkage of the immunological repertoire. 
In chapter 3, we performed a comparative study of the B 
cell compartment of centenarian offspring (CO) and their 
age-matched controls (AM). In particular, we observed as 
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CO don’t show the typical naïve/memory shift of the elderly. 
This trend was confirmed also after the evaluation of 
immunoglobulins secreted in the serum. The concentration 
of IgM, a marker of the primary response, has shown higher 
levels in CO when compared to AM. All these data suggest a 
good bone marrow cell reservoir, supporting the hypothesis 
of a “familiar youth” of the immune system that could be a 
big advantage both to fight the main age-related diseases and 
to properly respond to vaccinations. 
In chapter 4,  we have analyzed blood lymphocyte 
subsets and the expression of activation markers on 
peripheral blood mononuclear cells (PBMC) from AD 
patients and their age-matched controls (HC) after in vitro 
activation with human recombinant amyloid beta peptide 
(rAβ-42). We have reported a basal expression of the 
activation marker CD69 and of the chemokine receptors 
CCR2 and CCR5 on T cells, and CCR2 on B lymphocytes 
after activation. We reported also the increased expression of 
the scavenger receptor CD36 on monocytes from AD 
subjects with or without stimulation. PBMC of AD patients 
stimulated in vitro with rAβ-42 are able to produce different 
chemokines and cytokines. These data support the 
involvement of the immune system   in Alzheimer’s disease. 
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In chapter 5, we have reviewed recent works on B cell 
immunosenescence, focusing our attention on memory B cell 
subsets. We discussed about the origin and function of a 
specific memory B cells, IgG+IgD-CD27-, that is expanded 
in elderly people and in patients suffering by the chronic 
stimulation of the immune system, such as SLE and in 
healthy subjects challenged with RSV, but reduced in 
centenarian offspring and not increased in patients affected 
by Alzheimer’s disease. We hypothesized that the expansion 
of these memory B cells might be the  manifestation of an 
age-related physiologic modification (elderly) or a 
pathologic deregulation (SLE patients) of the immune 
system. Alternatively they might develop outside the 
germinal center (idea supported by the low rate of somatic 
hypermutation) or they might represent the first wave of 
memory B cells. Again, they could be represent 
exhausted/terminally differentiated memory B cells. 
In chapter 6, we gained insight into the biological 
significance of the naïve/memory B cell subsets and their 
different function in young and elderly people, evaluating 
surface immunoglobulins (Igs), production of pro- and anti-
inflammatory cytokines and somatic hypermutation.  Our 
data suggest that naïve B cells (IgD+CD27-) of young 
subjects need an adequate stimulus to be activated “in vitro”, 
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while the elderly has higher “in vitro” basal levels of IL-10 
and TNF-α, maybe because they are basally activated, 
possibly by bacteria or viruses. Moreover, we evaluated the 
level of mutation in the V region of IgG genes in the DN 
(IgG+IgD-CD27-) B cells, observing as the rate of mutations 
is lower in the elderly. As we know that memory B cells are 
characterized by  the high rate of somatic hypermutations, 
we hypothesized a different origin for these cells. 
In chapter 7, we have tested the hypothesis that patients 
suffering from Alzheimer’s disease show systemic changes 
at the immunological level, which mainly involve CD4+ T 
cells, consistent with chronic antigenic stress potentially 
resulting in immune exhaustion. We observed an increase in 
percentage of CD4+CD28-CD27- late differentiated cells in 
AD patients compared to healthy elderly controls and a 
contemporary reduction in naïve T cells 
(CD4+CD28+CD27+CD45RA+CD45RO-). We 
hypothesized that the differences in naïve/memory CD4+ T 
cell subsets are caused by chronic antigenic stimulation by 
Aβ present in the blood of AD patients. 
In chapter 8, we have shown our recent work about the 
naïve/memory B cells characterization based on two 
developmentally regulated markers, CD38 and CD24. We 
discussed about a new population of late memory B cells, 
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CD19+CD38-CD24-, that is increased in elderly people 
compared to young and contemporarily reduced in 
centenarian offspring when compared to age-matched 
controls. We evaluated the production of pro- and anti-
inflammatory cytokines by CD38/CD24 B cell subsets, 
confirming data in literature which affirm that 
CD19+CD38hiCD24hi (Breg) is the main IL-10-producing 
B cell population. We have also observed the higher 
production levels of TNF by CD19+CD38-CD24+ and 
CD19+CD38-CD24- B cells. Despite the increase of the 
number of markers using for characterization, we 
confirmed that centenarian offspring (CO) have the B cell 
branch similar  to young people but  different to their healthy 
age-matched controls. The immunological profile of 
centenarian offspring could guarantee them a 
protection against the risk of infection and the inflammatory 
processes of ageing. 
 Conclusions 
 
“More than 1000 scientific paper on the biology of aging 
and longevity are published every month” (Hugo Aguilaniu, 
CNRS, Lyon). A long life in healthy, vigorous, youthful 
body has always been one of the humanity greatest dreams. 
The aspiration to delay aging and achieve immortality has 
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led researchers to study the characteristics of centenarians. 
Indeed, centenarians may represent the prototypes of 
successful aging, who have escaped major age-related 
diseases, reaching the extreme limit of human life in good 
clinical condition. The interest in centenarians as a model for 
healthy aging is driven by the desire to identify key factors 
associated with exceptional longevity in humans. 
Subsequently, the study of centenarian offspring came from 
the idea to find markers of successful aging in people 
genetically advantaged for longevity. Centenarian offspring, 
like their centenarian parents, have genetic and functional 
advantages that predispose them to healthy aging and longer 
survival. 
In the present thesis we have focused our attention on the 
immunological changes that occur in old people and their 
relationship with the age-related pathologies. We try to 
explain the distinct roles played by humoral and cellular 
responses in protective immunity and the memory B and T 
cell differentiation in long-lived subjects. In contrast to T 
cells, B lymphocytes have not been extensively studied in 
the elderly, although B cell compartment is defective too 
(Cancro MP et al., 2009;  Frasca D et al., 2011); indeed, in 
elderly people, the quality and the size of the antibody 
response is substantially impaired, the number of circulating 
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B cells is reduced and a shift from the naïve (CD27-) to 
memory (CD27+) B cells was also described (Gupta S et al., 
2005; Listì F et al., 2006; Colonna-Romano G et al., 2008). 
Studying B cell populations in the elderly, our attention has 
been drawn to B lymphocytes negative for both IgD and 
CD27. We demonstrated that these cells are significantly 
increased in the elderly (Colonna-Romano G et al., 2009). 
Others have shown that the same population is expanded in 
patients suffering by the chronic stimulation of the immune 
system, such as SLE, HIV and in healthy subjects challenged 
with RSV (Wei C et al., 2007; Sanz I et al., 2008; Cagigi A 
et al., 2009). Recently, we have also observed that CD27- 
memory B cells have a low rate of somatic hypermutation 
when compared with classical CD27+ memory B cells 
(Buffa S et al., 2011). All these data support the hypothesis 
that these cells are senescent memory B cells that have 
down-modulated the expression of CD27, as specific CD8 T 
cells versus chronic antigenic stimuli, like infection with 
herpes viruses (e.g. CMV) (Pawelec G et al., 2005). Another 
hypothesis is that these cells might develop outside the 
germinal center (idea supported by the low rate of somatic 
hypermutation) or, alternatively, they might represent the 
first wave of memory B cells.   
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Moreover, it has been known that naïve and memory B 
cells produce different pro- and anti-inflammatory cytokines 
(Duddy ME et al., 2004, 2007; Sanz I et al., 2007, 2008; 
Lund FE, 2008). We have evaluated whether changes in the 
relative proportions of different B cell  populations could 
affect the cytokine environment. In our recent paper we 
observed that under physiological stimulation (anti-CD40 
and IL-4) both in young and in old people, a population of 
memory unswitched B cells (IgD+CD27+) is involved in IL-
10 and TNF-α production. Interestingly, in the elderly, naïve 
(IgD+CD27-) B cells are also highly activated to produce 
cytokines under these conditions. Moreover, both memory 
unswitched than naïve B cells produce IL-10 with a strong 
activation (CpG/PMA/Ionomycin). We have observed that 
old donors behave similarly to young. So, we have 
hypothesized that naïve B cells from young donors need an 
adequate stimulus to be activated in  vitro, while B cells 
from old subject have higher in vitro basal levels of IL-10 
and TNF-α production, maybe because they may already be 
basally activated (e.g. by bacteria or viruses). We imagine a 
scenario where IL-10 production by naïve B cells may act as 
a control mechanism to prevent the exacerbation of 
inflammation, while IL-10 production by memory B cells 
might be active in the resolution of the disease.  
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On the other hand, we have studied the B cell 
compartment of centenarian offspring, comparing all the 
data with those observed in age-matched controls, trying to 
understand whether any differences exist.  CO don’t show 
the typical naïve/memory shift observed in elderly. In 
particular, we didn’t see the increase of DN (IgD-CD27-) B 
cells. Also the evaluation of IgM secreted in the serum by 
CO shows that the values are within the range of the levels 
observed in young subjects. In our manuscript in 
preparation, we have characterized a new population of 
memory B cells (CD38-CD24-) that result increased in the 
elderly. Again, comparing data obtained by CO with those 
observed in their age-matched controls, we have shown as 
the percentage of this population is significantly reduced in 
centenarian offspring. We suggest that this B cell population, 
that is negative for IgD expression, may represent a late 
stage of differentiation of memory B cells and that its 
increase could be a typical phenomenon due to the aging of 
the immune system. They participate to the generation of the 
inflammatory environment of elderly people by producing 
pro-inflammatory cytokines ,such as  TNF. We have also 
observed the increase in percentage of CD19+CD180- B 
cells in the elderly. This marker, recently described as 
homologous of TLR4 that regulates TLR4 signaling, could 
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be involved in the recognition of exogenous pathogens and 
subsequent activation of the immune system. So, the 
reduction in CD180 expression observed in the elderly could 
explain their increased susceptibility to GRAM- infectious 
diseases. On the other hand,  the difference of the immune 
system of CO, could be related with the major  ability of 
bone marrow to generate new B cells and to properly 
respond to new antigens and vaccinations. 
Besides,  it has been known that aging is associated with 
chronic, low-grade pro-inflammatory status that, interacting 
with the genetic background, is potentially linked to the 
most-important age-related diseases. Alzheimer’s disease 
(AD) is the most common form of dementia of elderly 
people. Many studies have reported alterations of the 
immune system in AD and the involvement of both the 
innate and acquired  branches of the immune system  (Vasto 
S et al., 2008; Britschgi M et al., 2007). In addition, low 
PBMC phagocytosis of amyloid beta (Avagyan H et al., 
2009), and the increased expression of pro-inflammatory 
molecules (Reale M et al., 2008) confirm this hypothesis.  A 
significant decrease of B and T cell percentage without 
changes of NK cells was previously reported  (Richartz-
Salzburger E et al., 2007). On the other hand, others 
investigators (Speciale L et al., 2007) reported no differences 
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in the percentage and absolute number of CD3+, CD4+, 
CD8+ and NK cells. In our previously study, we have 
reported a good response of T lymphocytes to beta amyloid; 
in fact, we have shown an over expression of CD69 
activation marker and of the chemokine receptors CCR2 and 
CCR5 on T cells of AD patients when stimulated with rAβ-
42. The same stimulus was able to induce production of 
different chemokines and pro-inflammatory cytokines by 
PMBC of AD patients. Moreover, some activation  markers 
and chemokines receptors are over-expressed in 
unstimulated AD cells when compared to controls. We think 
that this data confirm the existence of the pro-inflammatory 
status  that characterize AD patients. Our recent studies on 
AD patients revealed that the major changes are seen within 
the CD4+ T cell subset compared to healthy elderly controls 
(Pellicanò M et al., 2011), whereas the more marked changes 
in the CD8 subsets were seen equally in both AD and age-
matched controls. The age-associated changes seen in CD8+ 
T cells are predominantly caused by infection (e.g. CMV), 
because CMV-negative individuals do not manifest these 
changes at older age (Chidrawar S et al., 2009). In contrast, 
the CD4+ cells are only marginally affected by CMV 
serostatus (Derhovanessian E et al., 2010). So, we 
hypothesized that the differences in CD4+ naïve, memory 
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and late differentiated T cell distribution between AD and 
their age-matched controls are caused by chronic antigenic 
stimulation by Aβ present in the blood. So, we believe that 
the increasing knowledge of the immunological aspects  of 
different forms of dementia, could help us to see whether the 
differences we observed for CD4+ cells are specific to AD 
and they can be used as biomarkers for early diagnosis.  
Moreover, we have studied the B cell branch of AD 
patients, in order to clarify the modifications  that affect the 
immune system. Our observations about the B cell reduction 
both in percentage than in absolute number confirmed data 
discussed by Speciale (2007). In our previously work we 
observed an increased expression of the chemokine  receptor 
CCR5 on B cells, after stimulation with  rAβ-42, suggesting 
the involvement of B cells in the complex cellular alterations 
of this pathology. We have also shown a reduced capacity of 
B cells of AD patients to uptake Aβ compared to young and 
aged controls. We believe that the ineffective clearance of 
Aβ in the blood could explain the higher frequency of 
chronically stimulated CD4+ T cells. Further studies about 
the B cell branch of AD patients are necessary to understand 
its implication on the physiopathology of the disease. 
In conclusion, in the present thesis I have reported the 
experimental observations that I obtained from  the study of 
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the immune system during aging. I focused my attention on 
phenotypic, genetic and functional characteristics of  elderly 
people. Moreover, I have also studied the B cell branch in 
healthy centenarian offspring trying to find some 
immunological markers that could explain their genetically 
advantaged for longevity. On the other hand, the analysis of 
the immune system of AD patients was important to 
understand the relevant modifications that could be related 
with the unsuccessful aging and usefully for an early 
diagnosis of disease.   
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Sommario e discussione generale 
 
I cambiamenti progressivi e cumulativi del sistema 
immunitario con l’età, conosciuti con il termine di 
“Immunosenescenza” (Franceschi C et al., 1995; Pawelec G 
et al., 2005), hanno un grande impatto sulle performance del 
sistema immune nella tarda età, contribuendo alla ridotta 
abilità degli anziani di rispondere in maniera adeguata nei 
confronti di nuovi antigeni e vaccini (Grubeck-Loebenstein 
B et al., 2009). Il risultato più evidente di queste 
modificazioni risulta essere l’incrementata suscettibilità 
degli anziani alle malattie infettive. Questi cambiamenti 
avvengono in tutti i leucociti e, di conseguenza, riguardano 
sia le risposte immunitarie innate che quelle adattative. Il 
compartimento acquisito del sistema immunitario presenta 
evidenti variazioni negli anziani, infatti risultano 
compromesse sia la branca B che quella T, con il risultato di 
avere una riduzione del numero di linfociti vergini che non 
hanno mai incontrato l’antigene e,  nello stesso tempo, il 
riempimento dello spazio immunologico con cloni espansi di 
cellule memoria ed effettrici che hanno già incontrato 
l’antigene (Franceschi C et al., 2000; Miller JP, Cancro MP, 
2007).  
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La risposta umorale delle persone anziane è 
qualitativamente e quantitativamente ridotta rispetto ai 
giovani. La quantità dei diversi isotipi immunoglobulinici 
cambia con l’età: infatti, sebbene il numero delle cellule B 
sia ridotto, è stato descritto un incremento della 
concentrazione sierica di IgG, IgA e, in misura minore anche 
di IgE. Al contrario, la concentrazione sierica di IgM e IgD è 
diminuita (Listì F et al., 2006). 
Un elemento caratteristico dell’invecchiamento è 
rappresentato dallo stato di infiammazione cronica basale 
osservato negli anziani. In questo contesto, osserviamo un 
incremento generale nella produzione di citochine e 
marcatori di tipo pro-infiammatorio (Bruunsgaard H et al., 
2003a, b, c; Krabbe KS et al., 2004; Fulop T et al., 
2006;Cevenini E et al., 2010). Questa condizione determina 
un’aumentata regolazione della risposta infiammatoria, 
“Inflamm-aging”, che predispone gli anziani alla fragilità 
(Balistreri CR et al., 2008; Franceschi C et al., 2005; Lio D 
et al., 2004; Pes et al., 2004).  
Inoltre, è stato ipotizzato che stimoli antigenici cronici, 
come infezioni da parte di virus erpetici (es. CMV), possano 
accelerare il processo di invecchiamento (Pawelec G et al., 
2005; Akbar AN and Fletcher JM, 2005). Il logoramento 
continuo del sistema immunitario causato dalla stimolazione 
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antigenica cronica determina la generazione di risposte di 
tipo infiammatorio che sono implicate nelle malattie età-
correlate (Pawelec G et al., 2005; Vasto S et al., 2007).    
Una tipica malattia età-correlata è la malattia di 
Alzheimer (AD), che rappresenta una delle principali cause 
di invalidità tra gli anziani. I processi di immunosenescenza 
osservati a livello del sistema nervoso centrale dei pazienti 
AD, potrebbero essere dovuti, principalmente, alla ridotta 
neuroprotezione a livello microgliale che determinerebbe la 
comparsa di eventi neurodegenerativi età-correlati (Streit WJ 
and Xue Q-S, 2010). Inoltre, nei pazienti con AD è stata 
descritta una diversa distribuzione linfocitaria  e livelli 
diversi di citochine plasmatiche (Richartz-Salzburger E et 
al., 2007; Larbi A et al., 2009; Pellicanò M et al., 2011).  
In ogni modo, in questo scenario i soggetti centenari 
rappresentano un gruppo  di sopravvissuti selezionati in cui 
le malattie che normalmente causano mortalità nella 
popolazione insorgono più tardi. Queste persone sono 
considerate un esempio di invecchiamento con successo, un 
modello esente da malattie o dove l’insorgenza delle stesse è 
ritardato (Franceschi C, Bonafè M, 2003). Inoltre, i figli dei 
centenari (CO) hanno un background genetico che potrebbe 
predisporli alla longevità. Questi vantaggi sono evidenti, 
come la ridotta prevalenza di malattie età-correlate, in 
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particolare malattie cardiovascolari, ictus, infarto del 
miocardio e diabete mellito (Terry DF et al., 2004 a,b).  
L’obiettivo di questa tesi è di studiare i cambiamenti del 
sistema immunitario durante l’invecchiamento osservando, 
se esistono, dei collegamenti tra il background genetico, 
predittore di longevità, e il profilo immunologico. In questo 
contesto, abbiamo focalizzato la nostra attenzione 
principalmente, sul compartimento linfocitario B 
vergine/memoria dei figli di centenari. Invece, riguardo lo 
studio delle malattie età-correlate dovute al microambiente 
pro-infiammatorio degli anziani, abbiamo analizzato alcuni 
parametri immunologici delle persone affette dal morbo di 
Alzheimer. 
Nel capitolo 2, abbiamo effettuato una valutazione dei 
meccanismi dell’immunosenescenza. Abbiamo analizzato i 
cambiamenti del sistema immunitario degli anziani e la loro 
maggiore suscettibilità a malattie infettive e ad eventi 
patologici legati a processi infiammatori e ad episodi di 
autoreattività. Abbiamo discusso sulla relazione esistente tra 
infezione cronica da CMV e peggioramento delle condizioni 
di salute. Abbiamo valutato gli altri parametri immunologici 
che definiscono il profilo immunologico di rischio (IRP) che 
predice mortalità a 2, 4 e 6 anni. Infine abbiamo analizzato 
le modificazioni della branca B cellulare durante 
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l’invecchiamento e il restringimento del repertorio 
recettoriale. 
Nel capitolo 3, abbiamo effettuato uno studio 
comparativo tra il compartimento B dei figli dei centenari 
(CO) e i controlli della stessa età (AM). In particolare, 
abbiamo osservato come i CO non presentano il tipico 
spostamento vergine/ memoria delle persone anziane. 
Questo andamento è stato confermato anche a seguito della 
valutazione dei livelli sierici delle immunoglobuline. La 
concentrazione dell’ IgM, un marcatore della risposta 
primaria, ha mostrato livelli significativamente più elevati 
nei CO rispetto agli AM. Questi dati, nel loro insieme, 
suggeriscono una buona riserva midollare, supportando 
l’ipotesi della “giovinezza familiare” del sistema 
immunitario che potrebbe essere un grosso vantaggio, sia per 
combattere le principali malattie legate all’età, sia per 
rispondere efficacemente ai vaccini. 
Nel capitolo 4, abbiamo valutato nei pazienti AD e nei 
loro controlli età-correlati (HC), le popolazioni linfocitarie a 
livello ematico e l’espressione dei marcatori di attivazione 
nelle cellule mononucleate di sangue periferico (PBMC) 
dopo attivazione in vitro con il peptide ricombinate beta 
amiloide (rAβ-42). Abbiamo osservato un’espressione 
basale del marcatore di attivazione CD69, e dei recettori 
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chemochinici CCR5 sui linfociti T e del CCR2 e CCR5 sui 
linfociti T e B dopo attivazione. Inoltre, abbiamo visto nei 
monociti dei soggetti AD, sia con che senza attivazione, 
un’espressione incrementata del recettore scavenger CD36. 
Le PBMC dei pazienti affetti dal morbo di Alzheimer sono 
in grado di produrre diverse citochine e chemochine in 
seguito a stimolazione in vitro con rAβ-42. Questi dati 
supportano l’idea che prevede il coinvolgimento del sistema 
immunitario nella malattia di Alzheimer. 
Nel capitolo 5, abbiamo esaminato i lavori recenti 
sull’immunosenescenza dei linfociti B, centrando 
l’attenzione sulle popolazioni di cellule memoria. Abbiamo 
discusso sull’origine e funzione di una particolare 
popolazione di cellule B della memoria, IgG+IgD-CD27-, 
che è aumentata negli anziani e in pazienti che hanno 
malattie che stimolano cronicamente il loro sistema 
immunitario, come il LES, e in soggetti sani sottoposti a 
challenge con virus respiratorio sinciziale, ma che troviamo 
ridotta nei figli di centenari e non aumentata nei pazienti con 
Alzheimer. Abbiamo formulato un’ipotesi, secondo la quale 
l’aumento di queste cellule B memoria potesse essere dovuto 
a condizioni fisiologiche legate all’età (negli anziani) o 
rappresentare una de-regolazione patologica del sistema 
immunitario (pazienti con LES). Alternativamente, tali 
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cellule potrebbero svilupparsi al di fuori del centro 
germinativo (idea sostenuta dal basso numero di mutazioni 
ipersomatiche), o ancora rappresentare una prima ondata di 
cellule B memoria. Un’altra possibilità potrebbe essere 
quella di cellule B memoria esauste e/o terminalmente 
differenziate. 
Nel capitolo 6, abbiamo incrementato la nostra 
conoscenza circa il significato biologico delle 
sottopopolazioni vergini/memoria dei linfociti B, e la loro 
differente funzione nei giovani e negli anziani, valutando le 
immunoglobuline di superficie (Igs), la produzione di 
citochine pro- e anti-infiammatorie, e le ipermutazioni 
somatiche. I risultati che abbiamo ottenuto hanno 
evidenziato la necessità di uno stimolo adeguato per attivare 
in vitro le cellule vergini B (IgD+CD27-) dei giovani, 
mentre negli anziani le stesse cellule hanno livelli base più 
alti di IL-10 e TNF-α, probabilmente perché sono attivate 
già a livello basale a causa di infezioni da parte di virus e 
batteri. Inoltre, abbiamo valutato il livello di mutazioni nella 
regione V dei geni IgG nei linfociti B DN (IgG+IgD-CD27-
), osservando come queste fossero ridotte negli anziani. 
Poiché è risaputo che le cellule B della memoria hanno un 
alto tasso di ipermutazioni somatiche, abbiamo ipotizzato 
una diversa origine per queste cellule. 
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Nel capitolo 7, abbiamo valutato l’ipotesi secondo la 
quale i pazienti che soffrono di Alzheimer presentano 
cambiamenti sistemici a livello immunologico, 
principalmente nei linfociti T CD4+, a causa di uno stress 
antigenico cronico con conseguente esaurimento 
immunitario. Abbiamo osservato un aumento percentuale 
delle cellule differenziate tardive, CD4+CD28-CD27-, e una 
contemporanea riduzione di cellule vergini T 
(CD4+CD28+CD27+CD45RA+CD45RO-), nei pazienti AD 
rispetto agli anziani controlli in buona salute. Abbiamo 
ipotizzato che le differenze delle popolazioni 
vergini/memoria dei linfociti T CD4+ sono determinate dalla 
stimolazione antigenica cronica indotta da Aβ presente nel 
sangue dei pazienti con AD.  
Nel capitolo 8, abbiamo presentato un nostro lavoro 
recente sulla caratterizzazione dei linfociti B 
vergini/memoria basata sull’espressione di due marcatori di 
sviluppo regolato, CD38 e CD24.  Abbiamo discusso di una 
nuova popolazione di linfociti B della memoria tardivi, 
CD19+CD38-CD24-, che è incrementata negli anziani 
rispetto ai giovani e, contemporaneamente, ridotta nei figli 
dei centenari quando confrontati con i controlli della stessa 
età. Abbiamo valutato la produzione di citochine pro- e anti-
infiammatorie da parte delle popolazioni CD38/CD24, 
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confermando i dati in letteratura che affermano che la 
popolazione CD19+CD38hiCD24hi (Breg) è la principale 
popolazione B responsabile della produzione di IL-10 e, 
osservando come le popolazioni CD19+CD38-CD24+ e 
CD19+CD38-CD24- siano le principali responsabili della 
produzione di TNF. Nonostante l’incremento del numero di 
marcatori utilizzati per la caratterizzazione, confermiamo 
che i figli di centenari (CO) hanno una branca B linfocitaria 
simile a quella dei giovani ma differente da quella dei loro 
controlli sani della stessa età. Questo potrebbe garantire loro 
una maggiore protezione contro il rischio di infezioni e i 
processi infiammatori tipici dei soggetti anziani. 
 
Conclusioni 
 
“Più di 1000 articoli scientifici sulla biologia 
dell’invecchiamento e sulla longevità sono pubblicati ogni 
mese” (Hugo Aguilaniu, CNRS, Lione). Il raggiungimento 
di un’età avanzata in buona salute è sempre stato uno dei più 
grandi sogni dell’umanità. L’aspirazione di ritardare 
l’invecchiamento e raggiungere l’immortalità ha indotto i 
ricercatori a studiare le caratteristiche dei centenari. Questi 
ultimi, infatti, potrebbero rappresentare il prototipo di 
invecchiamento con successo, esenti da malattie età-
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correlate, raggiungendo i limiti estremi della vita umana in 
buone condizioni cliniche. L’interesse nello studio dei 
centenari, come modello di invecchiamento in buona salute, 
deriva dal desiderio di identificare quei fattori chiave 
associati con un’eccezionale longevità. Successivamente, 
sono stati studiati i figli dei centenari per cercare dei 
marcatori di invecchiamento con successo in persone 
geneticamente avvantaggiate per la longevità. I figli dei 
centenari, come i loro genitori, hanno vantaggi genetici e 
funzionali che li predispongono all’invecchiamento in buona 
salute e  ad una migliore sopravvivenza.  
Lo scopo di questa tesi è quello di studiare i cambiamenti 
immunologici che avvengono nei soggetti anziani e  in 
soggetti che presentano delle malattie età-correlate. 
Abbiamo provato a spiegare le distinte funzioni delle 
risposte cellulari e umorali nell’azione protettiva del sistema 
immunitario e le differenze osservate nelle cellule memoria 
B e T negli anziani. A differenza dei linfociti T, le cellule B 
degli anziani non sono state studiate in maniera esaustiva, 
sebbene il compartimento B di questi soggetti risulti essere 
interessato (Cancro MP et al., 2009;  Frasca D et al., 
2011).Infatti, negli anziani, la risposta anticorpale è 
sostanzialmente compromessa, il numero dei linfociti B 
circolanti è ridotto e si osserva anche la diminuzione delle 
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cellule vergini (CD27-) ed un contemporaneo incremento di 
quelle memoria (CD27+) (Gupta S et al., 2005; Listì F et al., 
2006; Colonna-Romano G et al., 2008). Durante questi tre 
anni, ho studiato il compartimento cellulare B in soggetti 
anziani, focalizzando l’attenzione su una particolare 
popolazione di  linfociti B che non esprime nè IgD e neppure 
CD27. Dagli esperimenti effettuati è stato possibile dedurre 
che queste cellule sono significativamente aumentate negli 
anziani (Colonna-Romano G et al., 2009). Altri ricercatori 
hanno dimostrato che la stessa popolazione risultava 
aumentata in pazienti che soffrivano di una stimolazione 
cronica del sistema immunitario, come nel LES, HIV e in 
soggetti sani sottoposti a challenge con virus respiratorio 
sinciziale (Wei C et al., 2007; Sanz I et al., 2008; Cagigi A 
et al., 2009). Recentemente abbiamo valutato il numero di 
mutazioni somatiche nella regione V delle IgG delle 
sottopopolazioni IgG+IgD-CD27- e IgG+IgD-CD27+. 
Dall’analisi dei dati ottenuti è emerso che  nelle cellule B 
CD27-  vi è un tasso di ipermutazioni somatiche ridotto 
rispetto alle cellule CD27+ (Buffa S et al., 2011). Questi dati 
supportano la tesi secondo la quale queste cellule siano una 
popolazione memoria senescente che ha down-regolato 
l’espressione del CD27, come succede ai linfociti T CD8+ 
specifici in seguito a stimolazione cronica, ad esempio nel 
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caso di infezione da virus erpetici (es. CMV) (Pawelec G et 
al., 2005). Un’altra ipotesi è che queste cellule possano 
svilupparsi al di fuori del centro germinativo (idea 
supportata dal basso numero di mutazioni somatiche) o, 
ancora,  rappresentare una prima “ondata” di cellule B della 
memoria. Inoltre, è  noto che le cellule vergini e memoria 
producono differenti citochine pro- e anti-infiammatorie 
(Duddy ME et al., 2004, 2007; Sanz I et al., 2007, 2008; 
Lund FE, 2008). A tal proposito abbiamo valutato se i 
cambiamenti nelle proporzioni relative delle differenti 
popolazioni B potessero influenzare l’ambiente citochinico. 
In un nostro recente lavoro abbiamo osservato la produzione 
di IL-10 e TNF-α, da parte di una popolazione di linfociti B 
memoria unswitched (IgD+CD27+), a seguito di uno stimolo 
fisiologico (anti-CD40 e IL-4). Negli anziani, però, anche i 
linfociti B vergini (IgD+CD27-) rispondono allo stimolo  
producendo citochine. Invece, con uno stimolo forte 
(CpG/PMA/Ionomycin) sia le cellule B memoria unswitched 
che le vergini di giovani e anziani producono IL-10.   
Quindi, abbiamo ipotizzato che i linfociti B vergini dei 
giovani necessitano di uno stimolo adeguato per poter essere 
attivati in vitro, mentre le cellule B degli anziani producono 
elevati livelli basali di IL-10 e TNF-α,, probabilmente 
perché sono già attivati, per esempio a causa di infezioni da 
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parte di batteri o virus. Pertanto, immaginiamo uno scenario 
in cui l’IL-10 prodotta dai linfociti B vergini possa agire 
come un meccanismo di controllo in grado di prevenire 
l’esacerbazione dei processi infiammatori, mentre l’ IL-10 
sintetizzata dalle cellule B della memoria possa avere un 
ruolo nella risoluzione della malattia. 
Inoltre, abbiamo studiato il compartimento cellulare B 
dei figli di centenari (CO), effettuando un’analisi 
comparativa con un gruppo di soggetti avente la stessa età, al 
fine di valutarne eventuali differenze. I CO non hanno la 
caratteristica distribuzione vergine/memoria che invece 
contraddistingue gli anziani. In particolare, non abbiamo 
osservato l’incremento della popolazione cellulare B DN 
(IgD-CD27-). Anche la valutazione dei livelli sierici della 
IgM nei CO ha mostrato dei livelli simili a quelli osservati 
nei giovani. Nel nostro lavoro in fase di preparazione, 
abbiamo caratterizzato una nuova popolazione di linfociti B 
memoria (CD38-CD24-) che è aumentata negli anziani. 
Ancora una volta, confrontando i dati ottenuti dall’analisi dei 
CO con quelli relativi ai loro controlli, abbiamo osservato 
come la percentuale di questa popolazione risultasse ridotta 
nei figli di centenari. Quindi, questi linfociti B, che non 
esprimono IgD, potrebbero costituire una popolazione 
memoria tardiva il cui incremento sembrerebbe essere 
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correlato al fisiologico invecchiamento del sistema immune 
e che contribuire alla generazione del caratteristico ambiente 
pro-infiammatorio dell’anziano, producendo TNF-α. Oltre 
alla popolazione descritta precedente, nei soggetti anziani, 
abbiamo osservato l’incremento di un altro gruppo di cellule 
B, ossia quelle CD19+CD180-. Il CD180, descritto di 
recente in letteratura, è un omologo del TLR4 e ne regola il 
pathway. Si pensa che possa essere coinvolto nel 
riconoscimento dei patogeni esogeni e nella successiva 
attivazione del sistema immune. Di conseguenza, la ridotta 
espressione del CD180 negli anziani potrebbe spiegare la 
loro incrementata suscettibilità alle infezioni da parte di 
batteri GRAM-. Inoltre, le differenze del sistema immune 
degli figli di centenari, potrebbero essere correlate con la 
maggiore capacità del midollo osseo di questi soggetti di 
generare nuove cellule B e di rispondere in modo migliore 
sia ai nuovi antigeni che alle vaccinazioni. 
Inoltre, è noto che l’invecchiamento è associato con uno 
stato pro-infiammatorio che, insieme al background 
genetico, aumenta il rischio di sviluppare diverse malattie 
età-correlate. La malattia di Alzheimer (AD) è la più comune 
forma di demenza negli anziani. Molti studi hanno riportato 
alterazioni del sistema immune innato e adattativo in 
pazienti con AD (Vasto S et al., 2008; Britschgi M et al., 
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2007). Tale ipotesi è stata confermata dalla valutazione della 
ridotta fagocitosi della proteina beta amiloide da parte delle 
PBMC (Avagyan H et al., 2009) e dall’aumentata 
espressione di molecole di tipo pro-infiammatorio (Reale M 
et al., 2008). Studi precedenti hanno riportato una riduzione 
significativa della percentuale di cellule B e T ma non di 
quelle NK (Richartz-Salzburger E et al., 2007). Altri 
ricercatori, invece, non hanno osservato differenze né in 
termine percentuale, né di numero assoluto, delle cellule 
CD3+, CD4+, CD8+ e NK (Speciale L et al., 2007). In un 
nostro lavoro precedente, abbiamo riportato una buona 
risposta dei linfociti T alla stimolazione con la proteina beta 
amiloide; i pazienti AD, infatti, a seguito della stimolazione 
con rAβ-42, presentavano l’ over-espressione del marcatore 
di attivazione CD69 e dei recettori chemochinici CCR2 e 
CCR5 sui linfociti T quando confrontati con i controlli sani. 
Inoltre, sempre in questi soggetti, lo stesso stimolo induceva 
l’incremento della produzione di diverse chemochine e 
citochine pro-infiammatorie da parte delle PBMC. 
Diversamente da ciò,  alcune popolazioni cellulari di 
soggetti  con malattia di Alzheimer non stimolate,  
presentavano  un’ over-espressione di alcuni marcatori di 
attivazione e recettori chemochinici rispetto i controlli. 
Questa è una chiara evidenza dello stato pro-infiammatorio 
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che caratterizza la malattia di Alzheimer. In un nostro 
recente studio, abbiamo osservato come i maggiori 
cambiamenti nei pazienti AD rispetto ai loro controlli, siano 
a livello della popolazione CD4+; invece, i cambiamenti del 
compartimento CD8+ , osservati sia nei soggetti con malattia 
di Alzheimer che nei loro controlli, sembrano essere causati 
fondamentalmente da infezioni (es. CMV). Soggetti negativi 
al CMV non presentano le stesse caratteristiche dei soggetti 
anziani (Chidrawar S et al., 2009). E’ stato dimostrato che i 
cambiamenti relativi ai linfociti T CD4+ sono condizionati 
solo marginalmente dalle infezioni da CMV 
(Derhovanessian E et al., 2010). Abbiamo  ipotizzato, 
pertanto, che le differenze nel compartimento T CD4+ di 
cellule vergini, memoria e differenziate tra i pazienti 
Alzheimer e i loro controlli, siano causate dalla stimolazione 
antigenica cronica della proteina Aβ presente nel sangue. 
Noi pensiamo che sia importante approfondire lo studio del 
sistema immunitario nelle diverse manifestazioni di 
demenza, per vedere se tali differenze osservate nel 
compartimento CD4+  siano specifiche della malattia di 
Alzheimer o possano essere utilizzate come dei marcatori 
biologici per fare una diagnosi precoce. 
Inoltre, abbiamo cominciato a studiare la branca B 
cellulare dei pazienti con malattia di Alzheimer, al fine di 
159 
 
avere un’idea più chiara circa i cambiamenti che affliggono 
il sistema immunitario di questi persone. Abbiamo 
confermato la riduzione sia percentuale che di numero 
assoluto dei linfociti B già discussa da Speciale (2007). In un 
nostro lavoro precedente, abbiamo osservato l’aumento 
dell’espressione del recettore chemochinico CCR5 sui 
linfociti B a seguito della stimolazione con rAβ-42, 
suggerendo il coinvolgimento della branca B nelle 
complesse alterazioni che caratterizzano la malattia. 
Abbiamo inoltre mostrato la ridotta capacità dei linfociti B 
dei pazienti AD di riconoscere il peptide Aβ rispetto ai 
giovani e agli anziani controllo. Noi crediamo che  
l’eliminazione inefficace di Aβ dal sangue possa essere 
correlata all’aumento dei linfociti T CD4+ cronicamente 
stimolati.   
Studi futuri sul compartimento cellulare B in pazienti con 
malattia di Alzheimer saranno necessari per comprendere il 
loro probabile coinvolgimento nella fisiopatologia della 
malattia. 
In conclusione, in questa tesi ho riportato le osservazioni 
sperimentali che ho ottenuto dallo studio del sistema 
immune durante l’invecchiamento. In particolar modo, mi 
sono occupato della caratterizzazione fenotipica, genetica e 
funzionale  del sistema immune dei soggetti anziani. Inoltre, 
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ho anche studiato il compartimento cellulare B nei figli di 
centenari col fine di trovare qualche marcatore 
immunologico di longevità. Lo studio del sistema 
immunitario dei soggetti con malattia di Alzheimer potrebbe 
permettere di identificare dei marcatori di invecchiamento 
senza successo, utili per una diagnosi precoce della malattia. 
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